DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	HOXC11; LMX1B; MAF; FSTL3; IL1B; CXCL10; HOXD8; WT1; EN2; PAX7; PAX3; HOXD10; TLX1; HOXD13; FOXL2; TCF15; FOXF2; MAFA; MEIS3; GATA5; ALX4; HOXC10; LHX3; FOXD3; NR2E1; SOX1; LHX2; HOXD9;	GO:0045944~positive regulation of transcription by RNA polymerase II	28	1138	2.46045694200351	0	0	0	0	0	0	0
down	LCE6A; LCE2B; KRT34; KRT75; KRT14; KRT6A; KRT6B; CDH3; CASP14; KRT9; KRT2; KRT17; KRT31; LCE3E; LCE1C; LCE1D; LCE1E; LCE1F; LCE1B; LCE3A; LCE2A; LCE2C; LCE2D; KRT27; SPRR4;	GO:0031424~keratinization	25	181	13.8121546961326	0	0	0	0	0	0	0
down	MRPL33; DAP3; MRPS22; MRPS35; MRPS21; MRPS6; MRPL51; MRPL21; MRPL50; MRPL30; MRPS31; MRPL24; CHCHD1; MRPL48; MRPL57; MRPL45; MRPL20; MRPL1; MRPL18; MRPL47; MRPL40; MRPL22; MRPL39; MRPL11; MRPS18C; MRPS18B;	GO:0070125~mitochondrial translational elongation	26	89	29.2134831460674	0	0	0	0	0	0	0
down	MRPL33; DAP3; MRPS22; MRPS35; MRPS21; MRPS6; MRPL51; MRPL21; MRPL50; MRPL30; MRPS31; MRPL24; CHCHD1; MRRF; MRPL48; MRPL57; MRPL45; MRPL20; MRPL1; MRPL18; MRPL47; MRPL40; MRPL22; MRPL39; MRPL11; MRPS18C; MRPS18B;	GO:0070126~mitochondrial translational termination	27	89	30.3370786516854	0	0	0	0	0	0	0
down	FCER1G; CSF2RB; SYK;	GO:0038156~interleukin-3-mediated signaling pathway	3	4	75	0.00010386819434804	0.00240831572676993	0.289792262231044	0.302568050135854	0.221158735007946	0.289688394036696	0.0206015179735297
down	ZPR1; CRLF1; MAP2K4;	GO:2000672~negative regulation of motor neuron apoptotic process	3	4	75	0.00010386819434804	0.00240831572676993	0.289792262231044	0.302568050135854	0.221158735007946	0.289688394036696	0.0206015179735297
down	RPS17; GSPT1; RPL22; RPL26; ETF1; RPS24; RPL30; PPP2CA; RBM8A;	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	9	117	7.69230769230769	0.00010417019621455	0.00240831572676993	0.290426507046191	0.303447781573011	0.221468765155984	0.290426507046191	0.0206015179735297
down	ENSA; PFKFB2; CTSV; THBS1; EIF2B2; NDUFA9; EIF2B3;	GO:0009749~response to glucose	7	67	10.4477611940298	0.00010628985954086	0.00243797134521684	0.29622983854039	0.309622360842538	0.22374015433352	0.29622983854039	0.0208552018031285
down	CD79A; CD22; BTK; BANK1; LAT2;	GO:0042113~B cell activation	5	28	17.8571428571429	0.0001108515800734	0.0025227394746392	0.308832502084496	0.322910652753817	0.228575958111353	0.308832502084496	0.0215803360213979
down	PSMB1; PSMA5; PSMC2; PSMD7; PSMC6; PSMD6; PSMD13;	GO:1902036~regulation of hematopoietic stem cell differentiation	7	68	10.2941176470588	0.00011576598591012	0.00261415749578437	0.322408270759688	0.337226316956183	0.233794861236254	0.322408270759688	0.0223623555817039
down	MEFV; CD33; ARRB2; CX3CR1;	GO:0032691~negative regulation of interleukin-1 beta production	4	14	28.5714285714286	0.00011726125108668	0.00262755403396552	0.326455323025336	0.341582024415518	0.235350935223551	0.326455323025336	0.0224769539373325
up	HOXA11; HOXA13; HOXD13; ALX4; HOXC10;	GO:0001501~skeletal system development	5	137	3.64963503649635	0.00012195269480286	0.00405695964710856	0.118172161263974	0.121708789413257	0.0964645815890643	0.118172161263974	0.0303601352405449
down	RNASET2; POP4; ENDOU; RPP38; TSEN2; POP5; CPSF3;	GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic	7	69	10.1449275362319	0.00012591675102902	0.00279015747751185	0.350426318113764	0.366795495747537	0.244530330498358	0.350426318113764	0.0238679168113201
down	IL6; CCL5; NOTCH1; CRLF3; ADIPOR1;	GO:0046427~positive regulation of receptor signaling pathway via JAK-STAT	5	29	17.2413793103448	0.00012840690330329	0.00279141275613796	0.357099598086452	0.374049309322486	0.247183288858835	0.356971191183149	0.0238786548739795
down	NGF; LYN; SHC1; NOTCH1; RASGRP4;	GO:0046579~positive regulation of Ras protein signal transduction	5	29	17.2413793103448	0.00012840690330329	0.00279141275613796	0.357099598086452	0.374049309322486	0.247183288858835	0.356971191183149	0.0238786548739795
down	DYSF; CCL5; ADAM8; PTPRJ; EPB41L4B; TNFSF18;	GO:0045785~positive regulation of cell adhesion	6	48	12.5	0.00013537212191505	0.00292102956398932	0.376199126801941	0.394338991138558	0.25461098798116	0.376199126801941	0.0249874393107289
up	BDNF; MAP1B; LHX2;	GO:0048675~axon extension	3	27	11.1111111111111	0.00013917216053838	0.00448044568442917	0.134718651401153	0.138893816217304	0.105631669848631	0.134718651401153	0.0335292802367736
down	PRNP; TBC1D10C; HOMER2; HOMER3;	GO:0070885~negative regulation of calcineurin-NFAT signaling cascade	4	15	26.6666666666667	0.0001468156455564	0.0031096960270058	0.407853863355703	0.427673975505818	0.266323581039325	0.407853863355703	0.0266013537512783
down	LCK; SLC39A6; MT1X; MT1F; MT1E;	GO:0006882~cellular zinc ion homeostasis	5	30	16.6666666666667	0.00014801395003816	0.0031096960270058	0.410886725305937	0.431164636461165	0.267476414967379	0.410886725305937	0.0266013537512783
down	GTF2F2; POLR2B; CCNH; POLR2G; CTR9; WDR61; PCID2;	GO:0006368~transcription elongation from RNA polymerase II promoter	7	71	9.85915492957746	0.00014838576991205	0.0031096960270058	0.411770511505943	0.432247747753806	0.267836314691253	0.411770511505943	0.0266013537512783
down	ITGB3; ITGB2; ITGA2B; SRF; ITGA3; COL17A1; ITGB6; MSLN;	GO:0007160~cell-matrix adhesion	8	96	8.33333333333333	0.00015006511333859	0.00312242625110944	0.416280624401258	0.437139675155322	0.269516943556114	0.416280624401258	0.0267102522390318
up	FN1; ITGA5; ANPEP; HSPG2; TGFBI; ADM2;	GO:0001525~angiogenesis	6	230	2.60869565217391	0.00015292478053341	0.00464841180510751	0.147878262775812	0.152618930972348	0.11239971369206	0.147878262775812	0.0347862496382954
up	IL1B; FLT4; CCBE1;	GO:0010575~positive regulation of vascular endothelial growth factor production	3	28	10.7142857142857	0.00015370499956768	0.00464841180510751	0.148479029582382	0.153397589568548	0.112763506389576	0.148479029582382	0.0347862496382954
down	DDX3X; TRIAP1; NGF; THBS1; CD27; ARRB2; YWHAE;	GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	7	72	9.72222222222222	0.0001607787426161	0.00329822871296283	0.445678674531851	0.468348477240722	0.279314141459423	0.445678674531851	0.0282141238192424
down	EDN1; CPE; SMPD3;	GO:0030072~peptide hormone secretion	3	5	60	0.00016438083315017	0.00334854102773757	0.455499288659147	0.478841366966473	0.282406271352008	0.455499288659147	0.0286445117644774
down	EDN1; THBS1; CXCL8; CYBA; CCL5; HAS2; ABCC2; SMPD3; KLF2;	GO:0071356~cellular response to tumor necrosis factor	9	125	7.2	0.00016647838923222	0.00336771908217693	0.46114513817327	0.484951547833479	0.284130492336105	0.46114513817327	0.0288085670952789
down	LYN; LCK; FES; HCK; FGR;	GO:0038083~peptidyl-tyrosine autophosphorylation	5	31	16.1290322580645	0.00016982939752685	0.00338844544517622	0.470257601751861	0.494713034995729	0.286841852422858	0.470087772354335	0.028985867162338
down	ITGB2; STAT1; CDH13; PLXND1; TGFB1I1;	GO:0043542~endothelial cell migration	5	31	16.1290322580645	0.00016982939752685	0.00338844544517622	0.470257601751861	0.494713034995729	0.286841852422858	0.470087772354335	0.028985867162338
down	AQR; UBB; POLR2B; CCNH; POLR2G; RBX1; COPS3;	GO:0006283~transcription-coupled nucleotide-excision repair	7	73	9.58904109589041	0.00017399580930399	0.00344795777212611	0.481446404344154	0.506849792502538	0.290185769330562	0.481446404344154	0.029494955011442
up	FN1; ITGA5; CDH2; LGALS4; COL16A1; SPOCK1; IGFBP7; TGFBI;	GO:0007155~cell adhesion	8	454	1.76211453744493	0.00017887599913901	0.00495884019835385	0.172257587170873	0.178518247140738	0.124335154911774	0.172257587170873	0.0371093311627027
down	CD14; CYBA; FCER1G; ISL1; PTPRJ; CARD9;	GO:0032760~positive regulation of tumor necrosis factor production	6	51	11.7647058823529	0.00018328788928057	0.00355945080982867	0.506791013860776	0.533917621474301	0.297659532191646	0.506607725971496	0.0304487028089675
down	DDX3X; IGF2; CALM1; PPP2CA; DAZAP2; SYAP1;	GO:0071902~positive regulation of protein serine/threonine kinase activity	6	51	11.7647058823529	0.00018328788928057	0.00355945080982867	0.506791013860776	0.533917621474301	0.297659532191646	0.506607725971496	0.0304487028089675
up	FSTL3; SPARC; CCBE1; LHX3;	GO:0030324~lung development	4	80	5	0.00018865057719241	0.00508846691994683	0.181481855259106	0.188273276038033	0.128659693645229	0.181481855259106	0.0380793888267359
up	CALU; PRSS23; FSTL3; FN1; CDH2; IGFBP7; NOTUM;	GO:0043687~post-translational protein modification	7	344	2.03488372093023	0.00019406774249608	0.0050968317634498	0.186499100538737	0.193679607011092	0.130996399330387	0.186499100538737	0.0381419868809703
up	FN1; REG1A; SPARC; TPM1;	GO:0042060~wound healing	4	82	4.8780487804878	0.00020654657247587	0.00528547382899801	0.198284709576839	0.206133479330922	0.136527284406553	0.198284709576839	0.0395536840927435
down	TERT; EDN1; GNAI3; MMP9; NQO2;	GO:1904707~positive regulation of vascular smooth muscle cell proliferation	5	33	15.1515151515152	0.0002207389115183	0.00422734906971205	0.609901612525072	0.643012449252818	0.32272028863976	0.609901612525072	0.0361621222965076
down	WDR12; MRPL1; SNU13; RSL1D1;	GO:0000470~maturation of LSU-rRNA	4	17	23.5294117647059	0.00022149873921917	0.00422734906971205	0.611779517723354	0.64522582734545	0.323166660520773	0.611779517723354	0.0361621222965076
down	IL33; IL6; CYBA; FCER1G; ISL1; CARD9;	GO:0032755~positive regulation of interleukin-6 production	6	53	11.3207547169811	0.00022203378224028	0.00422734906971205	0.613035272765421	0.646784407665944	0.323503220724092	0.613035272765421	0.0361621222965076
up	HOXD9; HOXA11; ALX4;	GO:0035115~embryonic forelimb morphogenesis	3	33	9.09090909090909	0.0002411675158126	0.00587037026295064	0.231038480148472	0.240685180780976	0.150006194835438	0.231038480148472	0.0439307389271859
down	DHX29; EIF2A; MRPL22;	GO:0042255~ribosome assembly	3	6	50	0.0002438903103793	0.00459445574571052	0.673137256646874	0.710452474134907	0.337053216551053	0.673137256646874	0.0393024725004772
down	ENSA; PRKAR2B; NES; CCNH; YWHAE; DYNLL1; MAPRE1; MASTL; FBXL7;	GO:0000086~G2/M transition of mitotic cell cycle	9	133	6.76691729323308	0.00025714733885229	0.00480173203895339	0.709212360554623	0.749070198076729	0.345185399172083	0.709212360554623	0.0410755814966373
down	MFNG; TM4SF1; RPL7L1; SF3B6;	GO:0001825~blastocyst formation	4	18	22.2222222222222	0.00026759901275275	0.00490261587514945	0.737502879146581	0.779515924148762	0.350895975113502	0.737235280133828	0.0419385747252782
down	ITGB2; LYN; CD14; ITGAM;	GO:0034142~toll-like receptor 4 signaling pathway	4	18	22.2222222222222	0.00026759901275275	0.00490261587514945	0.737502879146581	0.779515924148762	0.350895975113502	0.737235280133828	0.0419385747252782
down	IGHM; IL6; S100A7; SLC11A1; RPL30; LCE3A; NLRP10;	GO:0050829~defense response to Gram-negative bacterium	7	80	8.75	0.00029312934961878	0.00530363848099075	0.806985099500505	0.85388579543951	0.364359781576145	0.806985099500505	0.0453690528516291
down	FES; PPP2CA; LIF; RUNX3; PLEKHB1;	GO:0045595~regulation of cell differentiation	5	36	13.8888888888889	0.00031788453478109	0.00566105335927374	0.874818239717584	0.925997649817341	0.374758422623277	0.874500355182803	0.0484264962578679
down	STX11; GCA; RABEP1; VTI1B; DYSF;	GO:0061025~membrane fusion	5	36	13.8888888888889	0.00031788453478109	0.00566105335927374	0.874818239717584	0.925997649817341	0.374758422623277	0.874500355182803	0.0484264962578679
down	CD14; ANXA3; SLC11A1; NCF4; UNC13D; TYRO3;	GO:0006909~phagocytosis	6	57	10.5263157894737	0.00031871361171331	0.00566105335927374	0.876462432211622	0.928412750920893	0.375100798670599	0.876462432211622	0.0484264962578679
up	HTRA1; ADAM19; LHX3;	GO:0001890~placenta development	3	37	8.10810810810811	0.00033045351559279	0.0076695955479445	0.315913560906716	0.329792608561613	0.179766712482483	0.315913560906716	0.0573951871179765
down	TERT; CRLF1; CNTF; ARRB2; NES; ISL1; ADAM8; TYRO3; NGF;	GO:0043524~negative regulation of neuron apoptotic process	9	138	6.52173913043478	0.0003322336581153	0.00586543421872647	0.913310326158959	0.967796646089868	0.380646217796744	0.907953738849157	0.0501748367693125
down	IL33; IL1RL1; IL1RAP;	GO:0032754~positive regulation of interleukin-5 production	3	7	42.8571428571429	0.00034462924018263	0.00594617242701366	0.946696522781703	1	0.385671659131673	0.907953738849157	0.0508654977282101
down	CSNK2B; ADIPOR2; ADIPOR1;	GO:0033211~adiponectin-activated signaling pathway	3	7	42.8571428571429	0.00034462924018263	0.00594617242701366	0.946696522781703	1	0.385671659131673	0.907953738849157	0.0508654977282101
down	IL6; ALOX5; NOTCH1; CD83; PAX5; TREM1;	GO:0006959~humoral immune response	6	58	10.3448275862069	0.00034737885089186	0.00595243878028239	0.953207566847281	1	0.386884240965939	0.907953738849157	0.0509191021572554
up	HSPG2; XYLT1; GPC6;	GO:0006024~glycosaminoglycan biosynthetic process	3	38	7.89473684210526	0.0003556675650761	0.00806718704422611	0.339662524647676	0.354956229945949	0.186521656968939	0.339662524647676	0.060370551096813
down	THBD; PTHLH; ENDOU; PGF; FOSB; ADIPOR2; ABCC2;	GO:0007565~female pregnancy	7	86	8.13953488372093	0.00044080997028261	0.00746557815949574	1	1	0.423177571471314	0.907953738849157	0.0638629897758149
down	LYN; RGS2; PTPRJ; DUSP7; SPRY4;	GO:0043407~negative regulation of MAP kinase activity	5	39	12.8205128205128	0.00044436414749438	0.00748227029856145	1	1	0.424440780179544	0.907953738849157	0.0640057797759616
down	DDX3X; CCL5; DHX29; POLR2G;	GO:0045948~positive regulation of translational initiation	4	21	19.047619047619	0.00044695646467907	0.00748266771040307	1	1	0.425502554374476	0.907953738849157	0.0640091793664335
down	MTIF2; MRRF; MCTS1;	GO:0032790~ribosome disassembly	3	8	37.5	0.00046872050381052	0.00775785697500037	1	1	0.433499472834507	0.907953738849157	0.0663632380630178
down	XRCC6; XRCC5; XRCC4;	GO:0075713~establishment of integrated proviral latency	3	8	37.5	0.00046872050381052	0.00775785697500037	1	1	0.433499472834507	0.907953738849157	0.0663632380630178
up	WT1; HOXA11; HOXD11;	GO:0001658~branching involved in ureteric bud morphogenesis	3	42	7.14285714285714	0.00046881945261489	0.0103973736379927	0.447253757794614	0.467881813709669	0.211554948669466	0.447253757794614	0.0778084322383909
down	KRT6A; GNLY; S100A7; RPL30; PPBP; CXCL8;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	6	62	9.67741935483871	0.00048276792440371	0.0079452144846781	1	1	0.438371371555057	0.907953738849157	0.067965955289915
up	HOXD10; ALX4; HOXD9;	GO:0048704~embryonic skeletal system morphogenesis	3	44	6.81818181818182	0.00053310072116741	0.0110840524942724	0.506978785830209	0.532034519725077	0.225957664442372	0.506978785830209	0.0829471727625506
down	SRF; ANXA3; SRD5A1; YWHAE; RELN; EIF2B3;	GO:0021766~hippocampus development	6	64	9.375	0.00056426600392789	0.00908125342233124	1	1	0.463262389224801	0.907953738849157	0.0776840027753586
down	DDX3X; EDN1; CD14; CD27; NLRP12; RTKN2;	GO:1901224~positive regulation of NIK/NF-kappaB signaling	6	64	9.375	0.00056426600392789	0.00908125342233124	1	1	0.463262389224801	0.907953738849157	0.0776840027753586
down	NEK7; AATF; MAP3K14; MAP2K4; CKS1B; PIM2; RBL1;	GO:0007346~regulation of mitotic cell cycle	7	90	7.77777777777778	0.00056854244124782	0.00909980291953244	1	1	0.46449917449947	0.907953738849157	0.0778426812225998
down	CA1; SLC4A3; HBB; CYB5RL; CYB5R1;	GO:0015701~bicarbonate transport	5	42	11.9047619047619	0.00060545369753162	0.00943843225764645	1	1	0.475281152562323	0.907953738849157	0.0807394269930877
down	PRNP; PTPRJ; RYR2; HOMER2;	GO:0035584~calcium-mediated signaling using intracellular calcium source	4	23	17.3913043478261	0.00060590004537586	0.00943843225764645	1	1	0.475515806662437	0.907953738849157	0.0807394269930877
down	DDX3X; NLRP12; ADIPOR1; LITAF;	GO:1901223~negative regulation of NIK/NF-kappaB signaling	4	23	17.3913043478261	0.00060590004537586	0.00943843225764645	1	1	0.475515806662437	0.907953738849157	0.0807394269930877
down	DHX29; MCTS1; EIF5;	GO:0001731~formation of translation preinitiation complex	3	9	33.3333333333333	0.00061818055945361	0.00947768405099153	1	1	0.479089933576554	0.907953738849157	0.0810751996316596
down	HLA-B; HLA-H; HLA-G;	GO:0002480~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent	3	9	33.3333333333333	0.00061818055945361	0.00947768405099153	1	1	0.479089933576554	0.907953738849157	0.0810751996316596
down	SLC11A1; IL27RA; NLRP10;	GO:0002827~positive regulation of T-helper 1 type immune response	3	9	33.3333333333333	0.00061818055945361	0.00947768405099153	1	1	0.479089933576554	0.907953738849157	0.0810751996316596
up	PAX3; GAMT; LHX3; HSPG2;	GO:0009887~animal organ morphogenesis	4	111	3.6036036036036	0.00062365468963654	0.0117435354765523	0.58997733639617	0.62240738025727	0.242601674268615	0.58997733639617	0.0878823937833274
up	FSTL3; HTRA3; HTRA1;	GO:0030514~negative regulation of BMP signaling pathway	3	47	6.38297872340426	0.00063966601706688	0.0118219756487547	0.604484386128208	0.638386685032753	0.245631750553684	0.604484386128208	0.0884693984477819
down	RGS2; GRK6; RASGRP4; RGS18; HOMER2;	GO:0008277~regulation of G protein-coupled receptor signaling pathway	5	43	11.6279069767442	0.0006678003417635	0.0101848292961104	1	1	0.489497650512647	0.907953738849157	0.0871243506276345
up	HOXD9; HOXD10; DMBX1;	GO:0008344~adult locomotory behavior	3	48	6.25	0.00067798099010785	0.0123022732386843	0.640014054661812	0.676625028127636	0.25287985244481	0.640014054661812	0.0920636909856343
down	MEFV; ALOX5; NLRP12; ISL1; TYRO3; GPS2; TNFAIP8L2;	GO:0050728~negative regulation of inflammatory response	7	93	7.52688172043011	0.0006823612569754	0.0103526996956737	1	1	0.491982466279267	0.907953738849157	0.0885603687607164
down	ARHGAP4; HOMER1; HSH2D; EIF2A; SH2D4A; HOMER2;	GO:0009967~positive regulation of signal transduction	6	67	8.95522388059701	0.00070608294538976	0.0106021629892803	1	1	0.496111296431897	0.907953738849157	0.0906943591133288
down	TERT; RECQL4; XRCC6; ZNF365; XRCC5;	GO:0000723~telomere maintenance	5	44	11.3636363636364	0.00073482673942337	0.0109771809843092	1	1	0.501070572627255	0.907953738849157	0.093902385319821
up	HOXD9; HOXD10; MSC;	GO:0007519~skeletal muscle tissue development	3	50	6	0.00075893004811189	0.0128264921857269	0.714153175273293	0.757412188015671	0.266384446887275	0.713394245225181	0.0959866676756325
up	NR2E1; SPOCK1; SPARC;	GO:0048856~anatomical structure development	3	50	6	0.00075893004811189	0.0128264921857269	0.714153175273293	0.757412188015671	0.266384446887275	0.713394245225181	0.0959866676756325
down	IDH3B; CYBA; COX7A2; NQO2; SRD5A1; GLRX5;	GO:0022900~electron transport chain	6	68	8.82352941176471	0.00075900586460464	0.0112805310387415	1	1	0.505131501821568	0.907953738849157	0.0964973405946592
up	PRSS23; ELANE; CTSE; HTRA3; HTRA1; ANPEP; TRHDE;	GO:0006508~proteolysis	7	436	1.60550458715596	0.00077591122031761	0.0128264921857269	0.728580635878241	0.77435939787698	0.26899021707043	0.728580635878241	0.0959866676756325
up	IL1B; WT1; PAX3; HOXA11; LHX2; FOXL2; FOXF2; LHX3;	GO:0045893~positive regulation of transcription, DNA-templated	8	570	1.40350877192982	0.00078398399131196	0.0128264921857269	0.735376983850623	0.782416023329341	0.270211238497457	0.735376983850623	0.0959866676756325
down	FGR; FCER1G; SYK;	GO:0043306~positive regulation of mast cell degranulation	3	10	30	0.00079492267064174	0.0114637306364844	1	1	0.511163870479399	0.907953738849157	0.0980644896871525
down	EDN1; LIF; IL11;	GO:0046888~negative regulation of hormone secretion	3	10	30	0.00079492267064174	0.0114637306364844	1	1	0.511163870479399	0.907953738849157	0.0980644896871525
down	HCK; FGR; SYK;	GO:0050764~regulation of phagocytosis	3	10	30	0.00079492267064174	0.0114637306364844	1	1	0.511163870479399	0.907953738849157	0.0980644896871525
down	IL6; MMP9; TNFRSF1B;	GO:0150077~regulation of neuroinflammatory response	3	10	30	0.00079492267064174	0.0114637306364844	1	1	0.511163870479399	0.907953738849157	0.0980644896871525
down	MPHOSPH10; LSM1; SF3B1; SF3A3;	GO:0000375~RNA splicing, via transesterification reactions	4	25	16	0.00080124484373611	0.0114637306364844	1	1	0.512321467876424	0.907953738849157	0.0980644896871525
down	SH2D1B; CCL5; ADAM8; POLR3B;	GO:0045089~positive regulation of innate immune response	4	25	16	0.00080124484373611	0.0114637306364844	1	1	0.512321467876424	0.907953738849157	0.0980644896871525
down	MUC21; DSCAM; SPN; CDH13; PLXND1;	GO:0007162~negative regulation of cell adhesion	5	45	11.1111111111111	0.00080675069704061	0.0114637306364844	1	1	0.513202707525769	0.907953738849157	0.0980644896871525
down	ACTN1; LCP1; DPYSL3; LIMA1; PLS3;	GO:0051017~actin filament bundle assembly	5	45	11.1111111111111	0.00080675069704061	0.0114637306364844	1	1	0.513202707525769	0.907953738849157	0.0980644896871525
down	ALPL; CYBA; CCL5; STAT1; MBD2;	GO:0071407~cellular response to organic cyclic compound	5	45	11.1111111111111	0.00080675069704061	0.0114637306364844	1	1	0.513202707525769	0.907953738849157	0.0980644896871525
down	MFNG; TERT; BAMBI; NMD3; PLK2; PLXND1;	GO:0032092~positive regulation of protein binding	6	70	8.57142857142857	0.0008739988827644	0.0122993176110759	1	1	0.523737241672769	0.907953738849157	0.105212373116283
down	CCL5; CXCR1; CXCR2; CX3CR1; CXCL8; PPBP;	GO:0070098~chemokine-mediated signaling pathway	6	70	8.57142857142857	0.0008739988827644	0.0122993176110759	1	1	0.523737241672769	0.907953738849157	0.105212373116283
down	LST1; MAP2; RELN; LAMC2; EGFLAM;	GO:0016358~dendrite development	5	46	10.8695652173913	0.00088379309242459	0.0123773522991963	1	1	0.525067641464299	0.907953738849157	0.105879907282174
down	DUSP14; PPP2CA; GPS2; DUSP7;	GO:0000188~inactivation of MAPK activity	4	26	15.3846153846154	0.00091389601163727	0.0126169624734567	1	1	0.529239847613246	0.907953738849157	0.107929610839227
down	CEBPZ; PWP1; GNL2; AATF;	GO:0042254~ribosome biogenesis	4	26	15.3846153846154	0.00091389601163727	0.0126169624734567	1	1	0.529239847613246	0.907953738849157	0.107929610839227
down	DSCAM; THBS1; CCL5; GLMN;	GO:0042327~positive regulation of phosphorylation	4	26	15.3846153846154	0.00091389601163727	0.0126169624734567	1	1	0.529239847613246	0.907953738849157	0.107929610839227
up	SLIT3; SERPINE2; WT1; SESN2;	GO:0030308~negative regulation of cell growth	4	124	3.2258064516129	0.00093049388777832	0.0148700403453418	0.871872772848293	0.928632900002771	0.289575668149953	0.77535525035524	0.111279498734648
up	SPARC; FLT4; CCBE1;	GO:0010595~positive regulation of endothelial cell migration	3	54	5.55555555555556	0.00093868992159973	0.0148700403453418	0.878613766617351	0.936812541756534	0.290780258695312	0.77535525035524	0.111279498734648
down	TGFA; IGF2; PPBP; FGF5; PGF;	GO:0051781~positive regulation of cell division	5	47	10.6382978723404	0.0009661776889509	0.0132668442871361	1	1	0.536539707580325	0.907953738849157	0.11348891177156
down	ITGB2; ALOX5; ADAM8;	GO:0002523~leukocyte migration involved in inflammatory response	3	11	27.2727272727273	0.0010007600546551	0.0132668442871361	1	1	0.541411189568411	0.907953738849157	0.11348891177156
down	ALOX5; ALOX5AP; SYK;	GO:0019370~leukotriene biosynthetic process	3	11	27.2727272727273	0.0010007600546551	0.0132668442871361	1	1	0.541411189568411	0.907953738849157	0.11348891177156
down	CRLF1; STAT1; IL27RA;	GO:0070106~interleukin-27-mediated signaling pathway	3	11	27.2727272727273	0.0010007600546551	0.0132668442871361	1	1	0.541411189568411	0.907953738849157	0.11348891177156
down	SRF; SERPINB8; BVES;	GO:0090136~epithelial cell-cell adhesion	3	11	27.2727272727273	0.0010007600546551	0.0132668442871361	1	1	0.541411189568411	0.907953738849157	0.11348891177156
down	IL27RA; BANK1; C5AR2;	GO:1900165~negative regulation of interleukin-6 secretion	3	11	27.2727272727273	0.0010007600546551	0.0132668442871361	1	1	0.541411189568411	0.907953738849157	0.11348891177156
down	LILRB3; HLA-B; IL32; CRISP3; CD83; STAT1;	GO:0006952~defense response	6	72	8.33333333333333	0.00100195871718844	0.0132668442871361	1	1	0.541544742165963	0.907953738849157	0.11348891177156
down	CD79A; LYL1; IL11; PTPRJ; GPS2; NFAM1;	GO:0030183~B cell differentiation	6	72	8.33333333333333	0.00100195871718844	0.0132668442871361	1	1	0.541544742165963	0.907953738849157	0.11348891177156
down	GTF2F2; POLR2B; POLR2G; GTF2B;	GO:0050434~positive regulation of viral transcription	4	27	14.8148148148148	0.00103724401728567	0.0136103235241133	1	1	0.546565256240009	0.907953738849157	0.116427145158264
down	FGR; SYK; GLMN; CD14;	GO:0050715~positive regulation of cytokine secretion	4	27	14.8148148148148	0.00103724401728567	0.0136103235241133	1	1	0.546565256240009	0.907953738849157	0.116427145158264
down	NUAK1; CSNK2B; TAF11; TAF12; TAF4B; RBBP8; RPF2; PAK1IP1;	GO:1901796~regulation of signal transduction by p53 class mediator	8	131	6.10687022900763	0.00105171123739811	0.0137084082851467	1	1	0.5484472467825	0.907953738849157	0.117266194185308
down	ITGB3; TYRO3; FERMT3; BVES; TGFB1I1;	GO:0034446~substrate adhesion-dependent cell spreading	5	48	10.4166666666667	0.00105413094949292	0.0137084082851467	1	1	0.548829556903173	0.907953738849157	0.117266194185308
down	DYSF; ITGB3; CYBA; CDH13; PDCL3; PGF;	GO:0001938~positive regulation of endothelial cell proliferation	6	73	8.21917808219178	0.00107109679720319	0.0138671332011239	1	1	0.551166122481119	0.907953738849157	0.11862397886985
up	IL1B; CCBE1; ADM2; NR2E1;	GO:0045766~positive regulation of angiogenesis	4	131	3.05343511450382	0.00113348641626776	0.016394484687467	1	1	0.31365917831557	0.77535525035524	0.122687632021503
down	GSPT1; PCMT1; SNRPD3; ETF1;	GO:0006479~protein methylation	4	28	14.2857142857143	0.00117182219177203	0.014777134392346	1	1	0.562910920888264	0.907953738849157	0.12640842577127
down	ITGB2; CCL5; SYK; FERMT3;	GO:0007159~leukocyte cell-cell adhesion	4	28	14.2857142857143	0.00117182219177203	0.014777134392346	1	1	0.562910920888264	0.907953738849157	0.12640842577127
down	ITGB2; MMP9; COL7A1; LAMA3;	GO:0035987~endodermal cell differentiation	4	28	14.2857142857143	0.00117182219177203	0.014777134392346	1	1	0.562910920888264	0.907953738849157	0.12640842577127
down	DDX3X; CCL5; NOTCH1; SRPK1;	GO:0045070~positive regulation of viral genome replication	4	28	14.2857142857143	0.00117182219177203	0.014777134392346	1	1	0.562910920888264	0.907953738849157	0.12640842577127
down	TGFA; IGF2; EDN1; SMPD3;	GO:0045840~positive regulation of mitotic nuclear division	4	28	14.2857142857143	0.00117182219177203	0.014777134392346	1	1	0.562910920888264	0.907953738849157	0.12640842577127
up	IL1B; CERS1; KCNQ1;	GO:0035690~cellular response to drug	3	59	5.08474576271187	0.00119854248522844	0.0170877914322569	1	1	0.321203233755389	0.77535525035524	0.12787597214956
down	DDX3X; RECQL4; XRCC6; XRCC5; GTF2F2; DDX1;	GO:0032508~DNA duplex unwinding	6	75	8	0.00122029530868129	0.0151397195574558	1	1	0.567437318536798	0.907953738849157	0.129510097496831
down	POP4; RPP38; POP5;	GO:0001682~tRNA 5'-leader removal	3	12	25	0.00123740895324609	0.0151397195574558	1	1	0.569208118493201	0.907953738849157	0.129510097496831
down	SNRPF; SNRPG; SNRPD3;	GO:0008334~histone mRNA metabolic process	3	12	25	0.00123740895324609	0.0151397195574558	1	1	0.569208118493201	0.907953738849157	0.129510097496831
down	MEFV; THBS1; ARRB2;	GO:0032695~negative regulation of interleukin-12 production	3	12	25	0.00123740895324609	0.0151397195574558	1	1	0.569208118493201	0.907953738849157	0.129510097496831
down	HLA-B; AZGP1; HLA-G; HLA-H;	GO:0001916~positive regulation of T cell mediated cytotoxicity	4	29	13.7931034482759	0.00131816296579457	0.0158016819726731	1	1	0.576661863342396	0.907953738849157	0.135172739833678
down	PRNP; MT1X; MT1F; MT1E;	GO:0071280~cellular response to copper ion	4	29	13.7931034482759	0.00131816296579457	0.0158016819726731	1	1	0.576661863342396	0.907953738849157	0.135172739833678
down	LSM1; EOMES; LIF; CTR9; GNL3;	GO:0019827~stem cell population maintenance	5	51	9.80392156862745	0.00135370391915113	0.016095263332601	1	1	0.579986718085036	0.907953738849157	0.137684130510579
down	XRCC6; XRCC5; SYK; POLR3B; CD14;	GO:0032481~positive regulation of type I interferon production	5	51	9.80392156862745	0.00135370391915113	0.016095263332601	1	1	0.579986718085036	0.907953738849157	0.137684130510579
down	CYBA; SLC11A1; NCF4; GLRX5; TMX2; PRDX6;	GO:0045454~cell redox homeostasis	6	77	7.79220779220779	0.00138488366952094	0.0163990493061565	1	1	0.583036024868317	0.907953738849157	0.140282814779733
up	BDNF; MAP1B; CDH2;	GO:0007416~synapse assembly	3	63	4.76190476190476	0.00143604559669419	0.0199418708915556	1	1	0.344956807247124	0.77535525035524	0.149234389759981
down	CYP27B1; ALPL; EDN1; THBD; S100A7; CSF2RB; NOTCH1; SLC11A1;	GO:0032496~response to lipopolysaccharide	8	138	5.79710144927536	0.0014405135045229	0.0169887280918025	1	1	0.588055501375819	0.907953738849157	0.145327119380686
down	SCG5; ANXA3; NOTCH1; NES; NOSIP;	GO:0043086~negative regulation of catalytic activity	5	52	9.61538461538462	0.00146624392203909	0.0170710713263676	1	1	0.590679814387869	0.907953738849157	0.146031510257694
down	DDX3X; ENC1; EIF4E2; GZMB; RGS2; CNOT10;	GO:0017148~negative regulation of translation	6	78	7.69230769230769	0.00147326474999643	0.0170710713263676	1	1	0.591127140469469	0.907953738849157	0.146031510257694
down	HCK; PPP2CA; IRX3; BTK;	GO:0007498~mesoderm development	4	30	13.3333333333333	0.00147679710753335	0.0170710713263676	1	1	0.591577380727495	0.907953738849157	0.146031510257694
down	NGF; MMP9; ISL1; PLAUR;	GO:0043388~positive regulation of DNA binding	4	30	13.3333333333333	0.00147679710753335	0.0170710713263676	1	1	0.591577380727495	0.907953738849157	0.146031510257694
down	XRCC6; XRCC5; CYBA; RPL26;	GO:0071480~cellular response to gamma radiation	4	30	13.3333333333333	0.00147679710753335	0.0170710713263676	1	1	0.591577380727495	0.907953738849157	0.146031510257694
down	EOMES; SRF; CTR9;	GO:0001829~trophectodermal cell differentiation	3	13	23.0769230769231	0.00150649162676664	0.0170755257150631	1	1	0.594341646497707	0.907953738849157	0.146069614550977
down	TNFRSF1B; RGS2; NOTCH1;	GO:0010614~negative regulation of cardiac muscle hypertrophy	3	13	23.0769230769231	0.00150649162676664	0.0170755257150631	1	1	0.594341646497707	0.907953738849157	0.146069614550977
down	SRF; GTF2B; GTF2F2;	GO:0060261~positive regulation of transcription initiation from RNA polymerase II promoter	3	13	23.0769230769231	0.00150649162676664	0.0170755257150631	1	1	0.594341646497707	0.907953738849157	0.146069614550977
down	ITGB2; ITGAM; FGFRL1;	GO:0098742~cell-cell adhesion via plasma-membrane adhesion molecules	3	13	23.0769230769231	0.00150649162676664	0.0170755257150631	1	1	0.594341646497707	0.907953738849157	0.146069614550977
down	SHISA9; CNIH2; HOMER1;	GO:0098962~regulation of postsynaptic neurotransmitter receptor activity	3	13	23.0769230769231	0.00150649162676664	0.0170755257150631	1	1	0.594341646497707	0.907953738849157	0.146069614550977
down	FGF5; GTF2F2; POLR2B; POLR2G; FGFBP1; FGFRL1;	GO:0008543~fibroblast growth factor receptor signaling pathway	6	79	7.59493670886076	0.00156587502154482	0.0176798214641862	1	1	0.599730133251664	0.907953738849157	0.151238957423469
down	RPS17; RPL22; RPL26; RPS24; RPL30; NUP54; NUP210;	GO:0019083~viral transcription	7	109	6.42201834862385	0.00162784662226156	0.0182381431178767	1	1	0.605558943481302	0.907953738849157	0.156015022893482
down	IGF2; IL6; LIF; IL11; SHC1; PTPRJ; BANK1;	GO:0043410~positive regulation of MAPK cascade	7	109	6.42201834862385	0.00162784662226156	0.0182381431178767	1	1	0.605558943481302	0.907953738849157	0.156015022893482
down	MLC1; RABEP1; BVES; VTI1B; GDI2; AP4S1; HSPA6; AP1S2;	GO:0016192~vesicle-mediated transport	8	141	5.67375886524823	0.00163857914387444	0.0182561254199623	1	1	0.606355111767383	0.907953738849157	0.156168849368767
down	THBS1; ALOX5; STAT1; AIMP1;	GO:0001937~negative regulation of endothelial cell proliferation	4	31	12.9032258064516	0.00164825299878135	0.0182561254199623	1	1	0.607394110707454	0.907953738849157	0.156168849368767
down	PRNP; ITGB2; ITGAM; CEMIP;	GO:0090314~positive regulation of protein targeting to membrane	4	31	12.9032258064516	0.00164825299878135	0.0182561254199623	1	1	0.607394110707454	0.907953738849157	0.156168849368767
down	XRCC5; CKS1B; PPP1R8; RASGRP4; YME1L1; GNL3; PAK1IP1; ZPR1;	GO:0008283~cell population proliferation	8	142	5.63380281690141	0.00170918171032897	0.0188592663719253	1	1	0.612696071653432	0.907953738849157	0.161328313729822
down	EDN1; CXCL8; CCL5; HAS2; ABCC2; KLF2;	GO:0071347~cellular response to interleukin-1	6	81	7.40740740740741	0.00176430502305736	0.0193940397440229	1	1	0.617506758070074	0.907953738849157	0.165902939521022
down	ENC1; FES; LYN; ITGA3; RGS2; RELN; DPYSL3;	GO:0010976~positive regulation of neuron projection development	7	111	6.30630630630631	0.00179535506077244	0.0195875254383151	1	1	0.620148769054407	0.907953738849157	0.167558079237244
down	TRAF5; IL6; EDN1; SRF; ANXA3; TAF12; NFAM1;	GO:0051091~positive regulation of DNA-binding transcription factor activity	7	111	6.30630630630631	0.00179535506077244	0.0195875254383151	1	1	0.620148769054407	0.907953738849157	0.167558079237244
down	TDG; GLMN; KLF2;	GO:0040029~regulation of gene expression, epigenetic	3	14	21.4285714285714	0.00180953927392524	0.0196686115856128	1	1	0.621362258245107	0.907953738849157	0.168251716579886
down	THBS1; NOTCH1; CDH13; PGF;	GO:0002040~sprouting angiogenesis	4	32	12.5	0.0018330559489752	0.0198501560571181	1	1	0.623239022651569	0.907953738849157	0.169804707182878
down	KRT6A; ITGB3; CDH3; SLC11A1; EPB41L4B; SPRR3;	GO:0042060~wound healing	6	82	7.31707317073171	0.00187038887459834	0.0201794177470554	1	1	0.626253368073001	0.907953738849157	0.172621319036481
down	GTF2F2; POLR2B; CCNH; POLR2G;	GO:0006370~7-methylguanosine mRNA capping	4	33	12.1212121212121	0.00203172754382885	0.0205536256669951	1	1	0.638142522128718	0.907953738849157	0.175822415596529
down	TRMT11; METTL8; TRMT6; TRMT12;	GO:0030488~tRNA methylation	4	33	12.1212121212121	0.00203172754382885	0.0205536256669951	1	1	0.638142522128718	0.907953738849157	0.175822415596529
down	THBS1; STAT1; FOSB; ACTA1; MBD2;	GO:0009612~response to mechanical stimulus	5	57	8.7719298245614	0.00213476268353974	0.0209267862244592	1	1	0.646281617019724	0.907953738849157	0.179014552676463
down	CTSV; AFG3L2; NGF;	GO:0021675~nerve development	3	15	20	0.00214799487851469	0.0209267862244592	1	1	0.6469988897627	0.907953738849157	0.179014552676463
down	PRNP; HOMER2; HOMER3;	GO:0032703~negative regulation of interleukin-2 production	3	15	20	0.00214799487851469	0.0209267862244592	1	1	0.6469988897627	0.907953738849157	0.179014552676463
down	ARRB2; TYRO3; GPS2;	GO:0034122~negative regulation of toll-like receptor signaling pathway	3	15	20	0.00214799487851469	0.0209267862244592	1	1	0.6469988897627	0.907953738849157	0.179014552676463
down	IL6; LYN; PPP1CC;	GO:0060252~positive regulation of glial cell proliferation	3	15	20	0.00214799487851469	0.0209267862244592	1	1	0.6469988897627	0.907953738849157	0.179014552676463
down	HOMER1; HOMER3; HOMER2;	GO:2001256~regulation of store-operated calcium entry	3	15	20	0.00214799487851469	0.0209267862244592	1	1	0.6469988897627	0.907953738849157	0.179014552676463
down	PRNP; PEBP1; SERPINB8; SPINK7; COL7A1; UCHL5; SERPINB5; SERPINA1;	GO:0010951~negative regulation of endopeptidase activity	8	148	5.40540540540541	0.0021847955273715	0.0212143645707772	1	1	0.649932599900637	0.907953738849157	0.181474591617626
down	TRAF5; DDX1; MAP3K14; LITAF; CARD9; PLK2; PIM2; IL1F10; IL36G;	GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling	9	183	4.91803278688525	0.0021933118766293	0.0212263039754856	1	1	0.650682620818254	0.907953738849157	0.18157672517842
up	PLOD2; FADS2; AOX1; ALDH1L2; MSRB3; PXDN; CYP39A1;	GO:0055114~oxidation-reduction process	7	526	1.33079847908745	0.00222411331420014	0.027508641756499	1	1	0.394053053425124	0.77535525035524	0.205860091461901
down	LYN; HCK; CCL5; CD14;	GO:0031663~lipopolysaccharide-mediated signaling pathway	4	34	11.7647058823529	0.00224478502998382	0.0216525125574267	1	1	0.654536894978233	0.907953738849157	0.185222652356378
up	WT1; FOXG1; FOXL2; FOXF2; DMBX1; BHLHE41; ZNF703;	GO:0045892~negative regulation of transcription, DNA-templated	7	530	1.32075471698113	0.00231849540267504	0.0282177855106059	1	1	0.399212289270292	0.77535525035524	0.211166947371848
up	IL1B; CCND2; FLT4; KNDC1;	GO:0001934~positive regulation of protein phosphorylation	4	161	2.48447204968944	0.00236011488325039	0.0283782488371552	1	1	0.401400516887381	0.77535525035524	0.212367769839642
down	EDN1; GNAI3; GNAZ; GNAL; OXER1;	GO:0007193~adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	5	59	8.47457627118644	0.00245605929777515	0.0234828375828218	1	1	0.669567119044915	0.907953738849157	0.200879849412783
down	NGF; LCK; NLRP12; PDCD2; CASP14; BID;	GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process	6	87	6.89655172413793	0.00247488299575727	0.0234828375828218	1	1	0.670693291850219	0.907953738849157	0.200879849412783
down	PFKFB2; APTX; CILP2; PHOSPHO1; NT5C3A; ALPL;	GO:0016311~dephosphorylation	6	87	6.89655172413793	0.00247488299575727	0.0234828375828218	1	1	0.670693291850219	0.907953738849157	0.200879849412783
down	HOMER3; HOMER1; HOMER2;	GO:0007216~G protein-coupled glutamate receptor signaling pathway	3	16	18.75	0.00252321598469729	0.0234828375828218	1	1	0.673384887192071	0.907953738849157	0.200879849412783
down	MT1X; MT1E; MT1F;	GO:0010273~detoxification of copper ion	3	16	18.75	0.00252321598469729	0.0234828375828218	1	1	0.673384887192071	0.907953738849157	0.200879849412783
down	PFN2; ADIPOR1; STRAP;	GO:0010633~negative regulation of epithelial cell migration	3	16	18.75	0.00252321598469729	0.0234828375828218	1	1	0.673384887192071	0.907953738849157	0.200879849412783
down	ALOX5; ALOX5AP; ALOXE3;	GO:0019372~lipoxygenase pathway	3	16	18.75	0.00252321598469729	0.0234828375828218	1	1	0.673384887192071	0.907953738849157	0.200879849412783
down	LCP1; CARMIL2; PDPN;	GO:0044319~wound healing, spreading of cells	3	16	18.75	0.00252321598469729	0.0234828375828218	1	1	0.673384887192071	0.907953738849157	0.200879849412783
down	CSMD3; PREX1; RTN4IP1;	GO:0050773~regulation of dendrite development	3	16	18.75	0.00252321598469729	0.0234828375828218	1	1	0.673384887192071	0.907953738849157	0.200879849412783
down	IL6; STAT1; CTR9;	GO:0070102~interleukin-6-mediated signaling pathway	3	16	18.75	0.00252321598469729	0.0234828375828218	1	1	0.673384887192071	0.907953738849157	0.200879849412783
down	ATP6V1G1; ALAS2; SLC11A1; NCOA4; ERFE;	GO:0006879~cellular iron ion homeostasis	5	60	8.33333333333333	0.00262922907319807	0.0243915423255604	1	1	0.678824582983444	0.907953738849157	0.208653206071161
down	THBS1; ALOX5; HLA-G; STAT1; CX3CR1; PLK2;	GO:0016525~negative regulation of angiogenesis	6	89	6.74157303370786	0.0027538103109771	0.0254661886853216	1	1	0.685698767433298	0.907953738849157	0.217846081427873
up	FSTL3; TSPAN8; HOXA11; GAMT; CADM1; RAI14;	GO:0007283~spermatogenesis	6	407	1.47420147420147	0.00278173672752158	0.0315474233416652	1	1	0.421441599932034	0.77535525035524	0.236084191723795
down	ACTN1; FAT1; FHOD3; RHOG; TMOD1; CORO6; MYO1F;	GO:0007015~actin filament organization	7	121	5.78512396694215	0.00284258021104755	0.0261212496996262	1	1	0.690746991284555	0.907953738849157	0.223449686931067
up	IL1B; FLT4; EDA2R;	GO:0046330~positive regulation of JNK cascade	3	81	3.7037037037037	0.00286162192640727	0.0316225997271734	1	1	0.42515640197538	0.77535525035524	0.236646771938896
down	CCL5; CXCR1; CXCR2;	GO:0002407~dendritic cell chemotaxis	3	17	17.6470588235294	0.00293647740277092	0.0263198728439129	1	1	0.695945144456708	0.907953738849157	0.225148774069641
down	ALOX5; ALOX5AP; DPEP2;	GO:0006691~leukotriene metabolic process	3	17	17.6470588235294	0.00293647740277092	0.0263198728439129	1	1	0.695945144456708	0.907953738849157	0.225148774069641
down	ETFA; NDUFAF2; SDHB;	GO:0022904~respiratory electron transport chain	3	17	17.6470588235294	0.00293647740277092	0.0263198728439129	1	1	0.695945144456708	0.907953738849157	0.225148774069641
down	RIOK1; WDR3; SNU13;	GO:0030490~maturation of SSU-rRNA	3	17	17.6470588235294	0.00293647740277092	0.0263198728439129	1	1	0.695945144456708	0.907953738849157	0.225148774069641
down	IL33; THBS1; IL1RL1;	GO:0043032~positive regulation of macrophage activation	3	17	17.6470588235294	0.00293647740277092	0.0263198728439129	1	1	0.695945144456708	0.907953738849157	0.225148774069641
down	RBM39; SRPK1; C9orf78;	GO:0048024~regulation of mRNA splicing, via spliceosome	3	17	17.6470588235294	0.00293647740277092	0.0263198728439129	1	1	0.695945144456708	0.907953738849157	0.225148774069641
down	ITGB2; FCER1G; SYK;	GO:0071404~cellular response to low-density lipoprotein particle stimulus	3	17	17.6470588235294	0.00293647740277092	0.0263198728439129	1	1	0.695945144456708	0.907953738849157	0.225148774069641
down	CEACAM5; NOTCH1; PTRH2;	GO:2000811~negative regulation of anoikis	3	17	17.6470588235294	0.00293647740277092	0.0263198728439129	1	1	0.695945144456708	0.907953738849157	0.225148774069641
down	NGDN; EIF2A; RBM8A; ZNF706; PUM3;	GO:0006417~regulation of translation	5	62	8.06451612903226	0.00300183505840712	0.026467215353484	1	1	0.699427568608859	0.907953738849157	0.22640918993848
down	PRNP; ITGB2; EIF2S1; ITGAM;	GO:1901216~positive regulation of neuron death	4	38	10.5263157894737	0.00325103521020398	0.0279358866292749	1	1	0.712896859349408	0.907953738849157	0.238972682901254
down	LYN; CD79A; SYK; BTK; LAT2; IGHM; LCK;	GO:0050853~B cell receptor signaling pathway	7	125	5.6	0.00337237850070571	0.0286147270014029	1	1	0.719622301418742	0.907953738849157	0.244779704784681
down	STAT1; NOTCH1; PLXND1;	GO:0007221~positive regulation of transcription of Notch receptor target	3	18	16.6666666666667	0.0033889738467161	0.0286147270014029	1	1	0.720742924870814	0.907953738849157	0.244779704784681
down	CTR9; WDR61; GTF2F2;	GO:0032968~positive regulation of transcription elongation from RNA polymerase II promoter	3	18	16.6666666666667	0.0033889738467161	0.0286147270014029	1	1	0.720742924870814	0.907953738849157	0.244779704784681
down	KRT9; KRT2; KRT17;	GO:0045109~intermediate filament organization	3	18	16.6666666666667	0.0033889738467161	0.0286147270014029	1	1	0.720742924870814	0.907953738849157	0.244779704784681
down	MT1E; MT1F; MT1X;	GO:0045926~negative regulation of growth	3	18	16.6666666666667	0.0033889738467161	0.0286147270014029	1	1	0.720742924870814	0.907953738849157	0.244779704784681
down	EDN1; SRF; NMU;	GO:0045987~positive regulation of smooth muscle contraction	3	18	16.6666666666667	0.0033889738467161	0.0286147270014029	1	1	0.720742924870814	0.907953738849157	0.244779704784681
down	ITGB2; EDN1; HBB; KLF2;	GO:0045429~positive regulation of nitric oxide biosynthetic process	4	39	10.2564102564103	0.00354358997120507	0.02974733210327	1	1	0.727655278260687	0.907953738849157	0.254468378119186
down	MT1E; MT1F; MMP9; MT1X;	GO:0071276~cellular response to cadmium ion	4	39	10.2564102564103	0.00354358997120507	0.02974733210327	1	1	0.727655278260687	0.907953738849157	0.254468378119186
down	EIF2S1; CYBA; PRDX6; ALDH3B1; NCF4; VRK2;	GO:0034599~cellular response to oxidative stress	6	94	6.38297872340426	0.0035537492522959	0.02974733210327	1	1	0.728511595151844	0.907953738849157	0.254468378119186
down	CD14; ITGAM; CASP14; DAP3; BTK;	GO:0097190~apoptotic signaling pathway	5	65	7.69230769230769	0.0036300821364752	0.0302992242508661	1	1	0.731143976706142	0.907953738849157	0.259189443497686
up	CXCL10; SPARC; HSPG2;	GO:0016525~negative regulation of angiogenesis	3	89	3.37078651685393	0.00369867475831287	0.0384508063416275	1	1	0.45123832051417	0.77535525035524	0.287745450332938
down	KRT6A; IL6; FGR; LCE3A; IL27RA; CARD9;	GO:0050830~defense response to Gram-positive bacterium	6	95	6.31578947368421	0.00373246610870903	0.0310647822133412	1	1	0.735295823415679	0.907953738849157	0.265738275923766
up	FSTL3; WT1; HOXA11;	GO:0008584~male gonad development	3	90	3.33333333333333	0.00381266836822458	0.0392272477473003	1	1	0.454971249566772	0.77535525035524	0.293555926189997
down	ZW10; BID; NUP210; NIFK; IL1RAP; NDUFAF1; AFG3L2;	GO:0065003~protein-containing complex assembly	7	128	5.46875	0.00381670578053561	0.0316753958367528	1	1	0.738665066861278	0.907953738849157	0.270961663952905
down	SNRPF; SNRPG; SNRPD3; CPSF3;	GO:0006369~termination of RNA polymerase II transcription	4	40	10	0.00385351255343414	0.031763339764583	1	1	0.739874410259354	0.907953738849157	0.271713964986244
down	CYP27B1; PHOSPHO1; TXLNG;	GO:0030500~regulation of bone mineralization	3	19	15.7894736842105	0.00388182250470015	0.031763339764583	1	1	0.740935934621703	0.907953738849157	0.271713964986244
down	PRNP; ITGB2; PDCL3;	GO:0050730~regulation of peptidyl-tyrosine phosphorylation	3	19	15.7894736842105	0.00388182250470015	0.031763339764583	1	1	0.740935934621703	0.907953738849157	0.271713964986244
down	SPN; CX3CR1; SELPLG;	GO:0050901~leukocyte tethering or rolling	3	19	15.7894736842105	0.00388182250470015	0.031763339764583	1	1	0.740935934621703	0.907953738849157	0.271713964986244
down	TERT; RBL1; PLK2;	GO:2000773~negative regulation of cellular senescence	3	19	15.7894736842105	0.00388182250470015	0.031763339764583	1	1	0.740935934621703	0.907953738849157	0.271713964986244
down	PRNP; ITGB3; SLC11A1; GPRC5A; MAP2K4; MAP3K14;	GO:0032147~activation of protein kinase activity	6	96	6.25	0.00391776018819778	0.031967606241513	1	1	0.741606421538172	0.907953738849157	0.273461327032294
down	CD14; UBB; BTK; MAP3K14; CARD9;	GO:0007249~I-kappaB kinase/NF-kappaB signaling	5	67	7.46268656716418	0.00409798833795527	0.0332519220848571	1	1	0.746542070387798	0.907953738849157	0.284447783515652
down	LYN; LIF; NLRP12; TBC1D10C; SPRY4;	GO:0070373~negative regulation of ERK1 and ERK2 cascade	5	67	7.46268656716418	0.00409798833795527	0.0332519220848571	1	1	0.746542070387798	0.907953738849157	0.284447783515652
down	EIF4E2; IGF2; EDN1; BTF3; NOTCH1; ATP11A; NSRP1; COPS3; KLF2;	GO:0001701~in utero embryonic development	9	203	4.43349753694581	0.00422529177091202	0.0336131682523959	1	1	0.750349570928938	0.907953738849157	0.287538001019401
down	CYBA; PREX1; NCF4;	GO:0006801~superoxide metabolic process	3	20	15	0.00441606554495966	0.0345806422915793	1	1	0.755267592461244	0.907953738849157	0.295814089401671
down	EDN1; NMU; RYR2;	GO:0010460~positive regulation of heart rate	3	20	15	0.00441606554495966	0.0345806422915793	1	1	0.755267592461244	0.907953738849157	0.295814089401671
down	PLAU; GP1BA; PLAUR;	GO:0042730~fibrinolysis	3	20	15	0.00441606554495966	0.0345806422915793	1	1	0.755267592461244	0.907953738849157	0.295814089401671
down	SAP18; SMU1; NSRP1; RBM8A; IK;	GO:0000381~regulation of alternative mRNA splicing, via spliceosome	5	69	7.2463768115942	0.00460742121010405	0.0359823538472737	1	1	0.760613268039837	0.907953738849157	0.307804787086095
up	SOX1; MRAS; MSC;	GO:1990830~cellular response to leukemia inhibitory factor	3	97	3.09278350515464	0.00467067999268489	0.0405550082177116	1	1	0.481080039246544	0.77535525035524	0.303492181651021
down	GSPT1; CCNH; CRLF3; RBBP8; PLK2; PIM2;	GO:0000082~G1/S transition of mitotic cell cycle	6	100	6	0.00472759150243407	0.0368221231192258	1	1	0.764443005767785	0.907953738849157	0.314988447250514
down	XRCC6; XRCC5; INO80C; UCHL5; RECQL4;	GO:0006310~DNA recombination	5	70	7.14285714285714	0.00487831274180739	0.0376012886946992	1	1	0.768508419663606	0.907953738849157	0.321653683635031
down	DDX3X; IL6; THBS1; RPL26; KRT17;	GO:0045727~positive regulation of translation	5	70	7.14285714285714	0.00487831274180739	0.0376012886946992	1	1	0.768508419663606	0.907953738849157	0.321653683635031
down	YWHAE; NUP54; HOMER3; AP4S1;	GO:0006605~protein targeting	4	43	9.30232558139535	0.00489216904060796	0.0376012886946992	1	1	0.768508419663606	0.907953738849157	0.321653683635031
down	NDUFS3; CALM1; YWHAE; DYNLL1;	GO:0021762~substantia nigra development	4	43	9.30232558139535	0.00489216904060796	0.0376012886946992	1	1	0.768508419663606	0.907953738849157	0.321653683635031
down	ANXA3; LCP1; NOTCH1; PGF;	GO:0031100~animal organ regeneration	4	43	9.30232558139535	0.00489216904060796	0.0376012886946992	1	1	0.768508419663606	0.907953738849157	0.321653683635031
down	PPP2CA; ORMDL2; SMPD3;	GO:0006672~ceramide metabolic process	3	21	14.2857142857143	0.00499267255750446	0.0379729899739178	1	1	0.771725538533921	0.907953738849157	0.324833337573045
down	IL33; FCER1G; SYK;	GO:0032753~positive regulation of interleukin-4 production	3	21	14.2857142857143	0.00499267255750446	0.0379729899739178	1	1	0.771725538533921	0.907953738849157	0.324833337573045
down	THBS1; SPN; SYK;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	3	21	14.2857142857143	0.00499267255750446	0.0379729899739178	1	1	0.771725538533921	0.907953738849157	0.324833337573045
down	PFDN6; PSMG2; NDUFAF1;	GO:0051131~chaperone-mediated protein complex assembly	3	21	14.2857142857143	0.00499267255750446	0.0379729899739178	1	1	0.771725538533921	0.907953738849157	0.324833337573045
down	PRKAR2B; CX3CR1; RELN; AKAP7; NGF;	GO:0050804~modulation of chemical synaptic transmission	5	71	7.04225352112676	0.00516030667547374	0.0391457639209765	1	1	0.775044386428246	0.907953738849157	0.334865628306629
down	MT-ND3; PRNP; PRDX6; NDUFA6; ABCC2; NDUFA12;	GO:0006979~response to oxidative stress	6	102	5.88235294117647	0.00517572280762968	0.0391607286717539	1	1	0.775744306102926	0.907953738849157	0.334993641664131
down	RPL30; RPL22; RPL26; DRG1;	GO:0002181~cytoplasmic translation	4	44	9.09090909090909	0.00527620255887795	0.0397146719741899	1	1	0.77717644943727	0.907953738849157	0.339732253289923
down	POLR2B; MLF1; POLR2G; PWP1; POLR3B; DRG1;	GO:0006351~transcription, DNA-templated	6	103	5.8252427184466	0.00541109843420562	0.040340061554881	1	1	0.779409239832546	0.907953738849157	0.345082039675426
down	HLA-B; HLA-H; HCK; HLA-G; STAT1;	GO:0060333~interferon-gamma-mediated signaling pathway	5	72	6.94444444444444	0.00545364052375541	0.040340061554881	1	1	0.780177130709228	0.907953738849157	0.345082039675426
up	ABCA1; CXCL10; ADM2;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	3	103	2.9126213592233	0.00549177764654885	0.0405550082177116	1	1	0.506155515143034	0.77535525035524	0.303492181651021
up	SLIT3; BDNF; LHX2; DPYSL5;	GO:0007411~axon guidance	4	206	1.94174757281553	0.00555948264181927	0.0405550082177116	1	1	0.508921392274963	0.77535525035524	0.303492181651021
down	ITGB3; ITGB6; ITGB2;	GO:0033627~cell adhesion mediated by integrin	3	22	13.6363636363636	0.00561254293383029	0.040340061554881	1	1	0.783374577966233	0.907953738849157	0.345082039675426
down	NOTCH1; NINJ1; NINJ2;	GO:0042246~tissue regeneration	3	22	13.6363636363636	0.00561254293383029	0.040340061554881	1	1	0.783374577966233	0.907953738849157	0.345082039675426
down	MMP9; PLAUR; DOK1;	GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway	3	22	13.6363636363636	0.00561254293383029	0.040340061554881	1	1	0.783374577966233	0.907953738849157	0.345082039675426
down	GTF2B; TAF11; TAF12;	GO:0051123~RNA polymerase II preinitiation complex assembly	3	22	13.6363636363636	0.00561254293383029	0.040340061554881	1	1	0.783374577966233	0.907953738849157	0.345082039675426
down	CYP27B1; JPH2; SNX10;	GO:0055074~calcium ion homeostasis	3	22	13.6363636363636	0.00561254293383029	0.040340061554881	1	1	0.783374577966233	0.907953738849157	0.345082039675426
down	CYBA; SLC11A1; FCER1G; SIRPB1;	GO:0050766~positive regulation of phagocytosis	4	45	8.88888888888889	0.00567988040954659	0.0406523135946172	1	1	0.784206971260412	0.907953738849157	0.347753145435104
down	DOK2; SHC1; DOK3; DOK1; PLK2;	GO:0007265~Ras protein signal transduction	5	73	6.84931506849315	0.00575855023657201	0.0411143549978781	1	1	0.785913727258561	0.907953738849157	0.351705598250151
down	ARRB2; RHOG; CXCR1; CXCR2; CX3CR1;	GO:0060326~cell chemotaxis	5	74	6.75675675675676	0.00607527006347097	0.0431550402344546	1	1	0.790316451896614	0.907953738849157	0.369162285142295
down	GTF2F2; POLR2B; POLR2G; LSM1;	GO:0016070~RNA metabolic process	4	46	8.69565217391304	0.00610363081929122	0.0431550402344546	1	1	0.79092997223707	0.907953738849157	0.369162285142295
down	CD14; SLC11A1; ISL1; IL27RA;	GO:0032729~positive regulation of interferon-gamma production	4	46	8.69565217391304	0.00610363081929122	0.0431550402344546	1	1	0.79092997223707	0.907953738849157	0.369162285142295
down	HLA-G; ARRB2; PTPRJ; BANK1;	GO:0051898~negative regulation of protein kinase B signaling	4	46	8.69565217391304	0.00610363081929122	0.0431550402344546	1	1	0.79092997223707	0.907953738849157	0.369162285142295
down	UBB; RBX1; COPS3;	GO:0000715~nucleotide-excision repair, DNA damage recognition	3	23	13.0434782608696	0.00627650818538994	0.0439506450577906	1	1	0.792834552772222	0.907953738849157	0.37596814821315
down	MCU; YME1L1; AFG3L2;	GO:0006851~mitochondrial calcium ion transmembrane transport	3	23	13.0434782608696	0.00627650818538994	0.0439506450577906	1	1	0.792834552772222	0.907953738849157	0.37596814821315
down	RABEP1; COMMD1; EXOC6;	GO:0006893~Golgi to plasma membrane transport	3	23	13.0434782608696	0.00627650818538994	0.0439506450577906	1	1	0.792834552772222	0.907953738849157	0.37596814821315
down	MT-ND3; EDN1; ISL1;	GO:0071385~cellular response to glucocorticoid stimulus	3	23	13.0434782608696	0.00627650818538994	0.0439506450577906	1	1	0.792834552772222	0.907953738849157	0.37596814821315
up	SOX1; MAP1B; SPOCK1;	GO:0001764~neuron migration	3	109	2.75229357798165	0.00639425557295792	0.0405550082177116	1	1	0.532438975505482	0.77535525035524	0.303492181651021
up	CDH2; FLT4; C1QTNF1;	GO:0043410~positive regulation of MAPK cascade	3	109	2.75229357798165	0.00639425557295792	0.0405550082177116	1	1	0.532438975505482	0.77535525035524	0.303492181651021
down	SRF; LIF; CNTF; DPYSL3;	GO:0048666~neuron development	4	47	8.51063829787234	0.00654787232801313	0.0457408923057608	1	1	0.796239711910829	0.907953738849157	0.391282506893847
up	FOXG1; HSPG2; DMBX1; CDH2;	GO:0007420~brain development	4	217	1.84331797235023	0.00663898184533929	0.0405550082177116	1	1	0.537757529472482	0.77535525035524	0.303492181651021
up	WT1; PAX7; CCND2; FLT4; LHX3; NR2E1;	GO:0043066~negative regulation of apoptotic process	6	489	1.22699386503067	0.00663995178461407	0.0405550082177116	1	1	0.53783609455374	0.77535525035524	0.303492181651021
down	IK; PSMG2; ZW10;	GO:0007094~mitotic spindle assembly checkpoint	3	24	12.5	0.00698533420278435	0.0470756788047216	1	1	0.801562339302243	0.907953738849157	0.40270070582163
down	ENC1; PSMB1; PSMA5;	GO:0010499~proteasomal ubiquitin-independent protein catabolic process	3	24	12.5	0.00698533420278435	0.0470756788047216	1	1	0.801562339302243	0.907953738849157	0.40270070582163
down	PPP2CA; ADIPOR1; STRAP;	GO:0010719~negative regulation of epithelial to mesenchymal transition	3	24	12.5	0.00698533420278435	0.0470756788047216	1	1	0.801562339302243	0.907953738849157	0.40270070582163
down	SBDS; PPBP; CXCL8;	GO:0030595~leukocyte chemotaxis	3	24	12.5	0.00698533420278435	0.0470756788047216	1	1	0.801562339302243	0.907953738849157	0.40270070582163
down	CYP27B1; MEFV; SLC11A1;	GO:0034341~response to interferon-gamma	3	24	12.5	0.00698533420278435	0.0470756788047216	1	1	0.801562339302243	0.907953738849157	0.40270070582163
down	IGF2; ADIPOR1; ERFE;	GO:0046628~positive regulation of insulin receptor signaling pathway	3	24	12.5	0.00698533420278435	0.0470756788047216	1	1	0.801562339302243	0.907953738849157	0.40270070582163
down	YWHAE; NUP54; NUP210; DNAJC7; BAG1;	GO:1900034~regulation of cellular response to heat	5	77	6.49350649350649	0.0070986044299175	0.0470756788047216	1	1	0.80238235192557	0.907953738849157	0.40270070582163
up	SOX1; LMX1B; WT1; ZNF10; HOXD13; IGSF1; MAFA; ZNF703;	GO:0006355~regulation of transcription, DNA-templated	8	824	0.970873786407767	0.00720658274561126	0.042306879883059	1	1	0.545812601357792	0.77535525035524	0.316602260456447
down	IGF2; SYK; PAX5; LAMC2; EGFLAM; LAMA3;	GO:0009887~animal organ morphogenesis	6	111	5.40540540540541	0.00758456010052744	0.0497608639027847	1	1	0.808605816151032	0.907953738849157	0.42567065467223
up	IL1B; ITGA5; ZNF703; SEMA6D;	GO:0030335~positive regulation of cell migration	4	226	1.76991150442478	0.00761902266316494	0.0439525122418417	1	1	0.550757905815468	0.77535525035524	0.328917300613296
down	SLC11A1; NFAM1; IL33;	GO:0001819~positive regulation of cytokine production	3	25	12	0.00773972345709395	0.0503254786395417	1	1	0.810556026138734	0.907953738849157	0.430500553226694
down	NOTCH1; IL1F10; IL36G;	GO:0002437~inflammatory response to antigenic stimulus	3	25	12	0.00773972345709395	0.0503254786395417	1	1	0.810556026138734	0.907953738849157	0.430500553226694
down	CYP27B1; CTSV; LIF;	GO:0046697~decidualization	3	25	12	0.00773972345709395	0.0503254786395417	1	1	0.810556026138734	0.907953738849157	0.430500553226694
down	MT1E; MT1F; MT1X;	GO:0071294~cellular response to zinc ion	3	25	12	0.00773972345709395	0.0503254786395417	1	1	0.810556026138734	0.907953738849157	0.430500553226694
down	ARRB2; NLRP12; NLRC5; COMMD1; PYDC1;	GO:0032088~negative regulation of NF-kappaB transcription factor activity	5	79	6.32911392405063	0.00784408401370618	0.0508904604274523	1	1	0.811562928034558	0.907953738849157	0.435333591656405
down	ENSA; PPP1R8; PPP4R4; MASTL;	GO:0032515~negative regulation of phosphoprotein phosphatase activity	4	51	7.84313725490196	0.00853776819486285	0.0549078338089466	1	1	0.819625746706834	0.907953738849157	0.469699513451982
down	MRPL11; RPF2; MRPL20;	GO:0000027~ribosomal large subunit assembly	3	26	11.5384615384615	0.00854031714320957	0.0549078338089466	1	1	0.819870445748119	0.907953738849157	0.469699513451982
down	LYN; EIF2B2; EIF2B3;	GO:0014003~oligodendrocyte development	3	26	11.5384615384615	0.00854031714320957	0.0549078338089466	1	1	0.819870445748119	0.907953738849157	0.469699513451982
down	GZMB; BID; YWHAE;	GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	3	26	11.5384615384615	0.00854031714320957	0.0549078338089466	1	1	0.819870445748119	0.907953738849157	0.469699513451982
down	EDN1; CD52; NMU; CXCR2; CXCR1; C5AR2; CX3CR1;	GO:0007204~positive regulation of cytosolic calcium ion concentration	7	150	4.66666666666667	0.00855755459981522	0.0549078338089466	1	1	0.820481201969004	0.907953738849157	0.469699513451982
down	IGF2; XRCC5; ALOX5AP; NCF4; CWF19L1;	GO:0043085~positive regulation of catalytic activity	5	81	6.17283950617284	0.00864225154743936	0.0553294038630568	1	1	0.821013897006739	0.907953738849157	0.473305761150453
down	CPE; RABGGTB; QPCT; ATG3; UBL5;	GO:0006464~cellular protein modification process	5	82	6.09756097560976	0.00906163853033182	0.0566449636026965	1	1	0.824609106260195	0.907953738849157	0.484559488109995
down	EDN1; ALOX5AP; FOSB; LCE1D; ACER1;	GO:0071277~cellular response to calcium ion	5	82	6.09756097560976	0.00906163853033182	0.0566449636026965	1	1	0.824609106260195	0.907953738849157	0.484559488109995
down	ALOXE3; CYP4F11; ALOX5;	GO:0019369~arachidonic acid metabolic process	3	27	11.1111111111111	0.00938769726896749	0.0579372079332676	1	1	0.82617608033154	0.907953738849157	0.495613767458225
down	FES; MAPRE1; DRG1;	GO:0031116~positive regulation of microtubule polymerization	3	27	11.1111111111111	0.00938769726896749	0.0579372079332676	1	1	0.82617608033154	0.907953738849157	0.495613767458225
down	CDH3; CDH23; CDH13;	GO:0044331~cell-cell adhesion mediated by cadherin	3	27	11.1111111111111	0.00938769726896749	0.0579372079332676	1	1	0.82617608033154	0.907953738849157	0.495613767458225
down	CXCL8; CCL5; CDC5L;	GO:0044344~cellular response to fibroblast growth factor stimulus	3	27	11.1111111111111	0.00938769726896749	0.0579372079332676	1	1	0.82617608033154	0.907953738849157	0.495613767458225
down	LCK; HCK; AP1S2;	GO:0050690~regulation of defense response to virus by virus	3	27	11.1111111111111	0.00938769726896749	0.0579372079332676	1	1	0.82617608033154	0.907953738849157	0.495613767458225
down	CCL5; ARRB2; HOMER1;	GO:0051928~positive regulation of calcium ion transport	3	27	11.1111111111111	0.00938769726896749	0.0579372079332676	1	1	0.82617608033154	0.907953738849157	0.495613767458225
down	NQO2; ITGA3; CX3CR1; PLK2; NGF;	GO:0007613~memory	5	83	6.02409638554217	0.00949484634109754	0.0584746033649411	1	1	0.82685531525645	0.907953738849157	0.500210823201977
down	SPN; FAT1; CARMIL2; RHOG;	GO:0007163~establishment or maintenance of cell polarity	4	53	7.54716981132075	0.00966579566363091	0.0589047338245959	1	1	0.828264727725637	0.907953738849157	0.50389029940065
down	LCK; GLRX5; RUNX3; RTKN2;	GO:0030097~hemopoiesis	4	53	7.54716981132075	0.00966579566363091	0.0589047338245959	1	1	0.828264727725637	0.907953738849157	0.50389029940065
down	JTB; XRCC6; XRCC5; RELN;	GO:0045860~positive regulation of protein kinase activity	4	53	7.54716981132075	0.00966579566363091	0.0589047338245959	1	1	0.828264727725637	0.907953738849157	0.50389029940065
down	PSMD6; RUNDC3A; BAG1; GRPEL1;	GO:0050790~regulation of catalytic activity	4	53	7.54716981132075	0.00966579566363091	0.0589047338245959	1	1	0.828264727725637	0.907953738849157	0.50389029940065
down	DPYSL3; IL1F10; CRNN; NLRP12;	GO:0071345~cellular response to cytokine stimulus	4	53	7.54716981132075	0.00966579566363091	0.0589047338245959	1	1	0.828264727725637	0.907953738849157	0.50389029940065
down	IL33; EOMES; IGF2; EDN1; UBB; RBL1; STAT1; NOTCH1; FOSB; ISL1; CNBP; PAX5; ARID5A; GPS2; TDG; RUNX3; CTR9; ZC3H8; MBD2; STRAP; KLF2; E2F2;	GO:0000122~negative regulation of transcription by RNA polymerase II	22	847	2.5974025974026	0.00992199571416963	0.0603398194475493	1	1	0.829746417757346	0.907953738849157	0.516166489738236
down	ITGB3; EDN1; THBS1; ANXA3;	GO:0010595~positive regulation of endothelial cell migration	4	54	7.40740740740741	0.0102643346859692	0.0618855335755163	1	1	0.831411109563506	0.907953738849157	0.529389032378839
down	NOTCH1; KRT17; KRT27;	GO:0031069~hair follicle morphogenesis	3	28	10.7142857142857	0.0102823886888259	0.0618855335755163	1	1	0.832117121808082	0.907953738849157	0.529389032378839
down	MMP9; BID; PLAUR;	GO:0090200~positive regulation of release of cytochrome c from mitochondria	3	28	10.7142857142857	0.0102823886888259	0.0618855335755163	1	1	0.832117121808082	0.907953738849157	0.529389032378839
down	ATP6V1G1; ATP6V1E1; ATP6V0E2;	GO:0090383~phagosome acidification	3	28	10.7142857142857	0.0102823886888259	0.0618855335755163	1	1	0.832117121808082	0.907953738849157	0.529389032378839
down	GNAI3; CX3CR1; AATF;	GO:2001234~negative regulation of apoptotic signaling pathway	3	28	10.7142857142857	0.0102823886888259	0.0618855335755163	1	1	0.832117121808082	0.907953738849157	0.529389032378839
down	ZW10; SERPINA1; TGFA; DYNLL1; COL7A1; COG2; CNIH2; VTI1B;	GO:0006888~endoplasmic reticulum to Golgi vesicle-mediated transport	8	196	4.08163265306122	0.0106899166410583	0.0626270817587167	1	1	0.83381349800255	0.907953738849157	0.535732477324461
down	SRF; PFN2; RHOG; FGD2; PDCL3; SDAD1; FHL3;	GO:0030036~actin cytoskeleton organization	7	157	4.45859872611465	0.0107175357814293	0.0626270817587167	1	1	0.834685384529712	0.907953738849157	0.535732477324461
down	NEK7; TUBB1; MAPRE2; MAPRE1;	GO:0051225~spindle assembly	4	55	7.27272727272727	0.0108863395736611	0.0634238143561498	1	1	0.83558970238944	0.907953738849157	0.542547987742661
down	EDN1; SRF; PLXND1;	GO:0001569~branching involved in blood vessel morphogenesis	3	29	10.3448275862069	0.0112248610850567	0.0644931367668051	1	1	0.837476974444527	0.907953738849157	0.551695320302815
down	PPP4R4; CTR9; RBBP8;	GO:0001835~blastocyst hatching	3	29	10.3448275862069	0.0112248610850567	0.0644931367668051	1	1	0.837476974444527	0.907953738849157	0.551695320302815
down	ALPL; PHOSPHO1; SMPD3;	GO:0001958~endochondral ossification	3	29	10.3448275862069	0.0112248610850567	0.0644931367668051	1	1	0.837476974444527	0.907953738849157	0.551695320302815
down	HLA-B; HLA-H; HLA-G;	GO:0002474~antigen processing and presentation of peptide antigen via MHC class I	3	29	10.3448275862069	0.0112248610850567	0.0644931367668051	1	1	0.837476974444527	0.907953738849157	0.551695320302815
down	UBB; CCNH; RBX1;	GO:0006294~nucleotide-excision repair, preincision complex assembly	3	29	10.3448275862069	0.0112248610850567	0.0644931367668051	1	1	0.837476974444527	0.907953738849157	0.551695320302815
down	IL33; PRNP; IL1RL1;	GO:0032689~negative regulation of interferon-gamma production	3	29	10.3448275862069	0.0112248610850567	0.0644931367668051	1	1	0.837476974444527	0.907953738849157	0.551695320302815
down	MELTF; SLC11A1; SLC25A37;	GO:0055072~iron ion homeostasis	3	29	10.3448275862069	0.0112248610850567	0.0644931367668051	1	1	0.837476974444527	0.907953738849157	0.551695320302815
down	TGFA; THBS1; UBB; SHC1; DUSP7; MAP2K4;	GO:0000187~activation of MAPK activity	6	122	4.91803278688525	0.011514862726388	0.0657399291206177	1	1	0.839476919458126	0.907953738849157	0.562360788621946
down	TRIAP1; RPL26; CNOT10; PLK2;	GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	4	56	7.14285714285714	0.0115321331207126	0.0657399291206177	1	1	0.839476919458126	0.907953738849157	0.562360788621946
down	IMPDH2; RRM1; RPGRIP1; PFDN5;	GO:0060041~retina development in camera-type eye	4	56	7.14285714285714	0.0115321331207126	0.0657399291206177	1	1	0.839476919458126	0.907953738849157	0.562360788621946
down	POLR2B; POLR2G; NUP54; NUP210;	GO:0060964~regulation of gene silencing by miRNA	4	56	7.14285714285714	0.0115321331207126	0.0657399291206177	1	1	0.839476919458126	0.907953738849157	0.562360788621946
down	ATP6V1G1; IGF2; SHC1; ATP6V1E1; ATP6V0E2;	GO:0008286~insulin receptor signaling pathway	5	88	5.68181818181818	0.0118754561581298	0.0674331457868072	1	1	0.841599938011023	0.907953738849157	0.57684511606865
down	IL6; LIF; IL11; ARRB2; PFN2;	GO:0033138~positive regulation of peptidyl-serine phosphorylation	5	88	5.68181818181818	0.0118754561581298	0.0674331457868072	1	1	0.841599938011023	0.907953738849157	0.57684511606865
up	IL1B; ELANE; SPARC;	GO:0032496~response to lipopolysaccharide	3	138	2.17391304347826	0.0119597284661199	0.0489222688590038	1	1	0.607541165030761	0.77535525035524	0.366108324467124
down	TGFA; CCL5; NOTCH1; C5AR2;	GO:0050679~positive regulation of epithelial cell proliferation	4	57	7.01754385964912	0.0122020268470271	0.0686946747160186	1	1	0.842711205534805	0.907953738849157	0.587636645858697
down	PUS3; TRMT6; TRIT1;	GO:0006400~tRNA modification	3	30	10	0.0122155308969782	0.0686946747160186	1	1	0.842871631891499	0.907953738849157	0.587636645858697
down	BID; FBXO7; TIMM8B;	GO:0006626~protein targeting to mitochondrion	3	30	10	0.0122155308969782	0.0686946747160186	1	1	0.842871631891499	0.907953738849157	0.587636645858697
down	EDN1; CSF2RB; NDUFA12;	GO:0007585~respiratory gaseous exchange by respiratory system	3	30	10	0.0122155308969782	0.0686946747160186	1	1	0.842871631891499	0.907953738849157	0.587636645858697
down	LAMC2; RHOG; EGFLAM;	GO:0008045~motor neuron axon guidance	3	30	10	0.0122155308969782	0.0686946747160186	1	1	0.842871631891499	0.907953738849157	0.587636645858697
down	TRAF5; TRIAP1; RSL1D1; ACTN1; STAT1; RABGGTB; BID; TNFAIP8L2;	GO:0042981~regulation of apoptotic process	8	202	3.96039603960396	0.0125594479366014	0.0691637701362028	1	1	0.8450412826008	0.907953738849157	0.591649441034514
down	PLAU; THBS1; SRF; CYBA; ALAS2; RYR2; PGF;	GO:0001666~response to hypoxia	7	163	4.29447852760736	0.0128628607583888	0.0696459356676332	1	1	0.847526698137861	0.907953738849157	0.595774042203523
down	NUAK1; LYN; XRCC5; APTX; MASTL; AATF; MCTS1; USP16; BCCIP;	GO:0006974~cellular response to DNA damage stimulus	9	245	3.6734693877551	0.0130104471845401	0.0701841345343804	1	1	0.847526698137861	0.907953738849157	0.60037797079286
up	MSC; MAF; PAX3; HOXD13;	GO:0006366~transcription by RNA polymerase II	4	266	1.50375939849624	0.0131150882603128	0.0489222688590038	1	1	0.619849752566443	0.77535525035524	0.366108324467124
down	CALM1; BVES; RYR2;	GO:0002027~regulation of heart rate	3	31	9.67741935483871	0.0132547631992528	0.0711070445661572	1	1	0.848832594436995	0.907953738849157	0.608272844125395
down	EDN1; THBS1; CSNK2B;	GO:0033574~response to testosterone	3	31	9.67741935483871	0.0132547631992528	0.0711070445661572	1	1	0.848832594436995	0.907953738849157	0.608272844125395
down	NOL8; SLIRP; RBM38;	GO:0051252~regulation of RNA metabolic process	3	31	9.67741935483871	0.0132547631992528	0.0711070445661572	1	1	0.848832594436995	0.907953738849157	0.608272844125395
up	CDH2; GPR158; RAB3B;	GO:0072659~protein localization to plasma membrane	3	144	2.08333333333333	0.013369231314955	0.049053282545313	1	1	0.622498683132967	0.77535525035524	0.367088761439808
down	THBS1; SRD5A1; TNFRSF1B; SHC1;	GO:0071363~cellular response to growth factor stimulus	4	59	6.77966101694915	0.0136153041335112	0.0729069502590406	1	1	0.851581849803592	0.907953738849157	0.623669824293079
down	LST1; IER3; FAT1; MRPL40; DKK3; SCML1;	GO:0009653~anatomical structure morphogenesis	6	127	4.7244094488189	0.0137056806670922	0.0732562344646598	1	1	0.851581849803592	0.907953738849157	0.626657715274294
down	KRT14; ITGB2; EIF2S1; TNFRSF1B; PAX5; LITAF; MBD2;	GO:0007568~aging	7	166	4.21686746987952	0.0140439504381561	0.0749267905244482	1	1	0.854531051015033	0.907953738849157	0.640948196505207
down	FES; MAP2; MAPRE1;	GO:0001578~microtubule bundle formation	3	32	9.375	0.014342873530507	0.0756392518761187	1	1	0.856087573876627	0.907953738849157	0.647042823209975
down	CD14; UBB; BTK;	GO:0002755~MyD88-dependent toll-like receptor signaling pathway	3	32	9.375	0.014342873530507	0.0756392518761187	1	1	0.856087573876627	0.907953738849157	0.647042823209975
down	AQP9; CRIP1; PPP2CA;	GO:0010033~response to organic substance	3	32	9.375	0.014342873530507	0.0756392518761187	1	1	0.856087573876627	0.907953738849157	0.647042823209975
down	FCER1G; OSCAR; SNX10;	GO:0030316~osteoclast differentiation	3	32	9.375	0.014342873530507	0.0756392518761187	1	1	0.856087573876627	0.907953738849157	0.647042823209975
down	DNAJC7; BAG1; HSPA6;	GO:0051085~chaperone cofactor-dependent protein refolding	3	32	9.375	0.014342873530507	0.0756392518761187	1	1	0.856087573876627	0.907953738849157	0.647042823209975
down	CPVL; CTSW; CTSV;	GO:0051603~proteolysis involved in cellular protein catabolic process	3	32	9.375	0.014342873530507	0.0756392518761187	1	1	0.856087573876627	0.907953738849157	0.647042823209975
down	CTSV; ALPL; IL6; ANXA3;	GO:0051384~response to glucocorticoid	4	60	6.66666666666667	0.0143592537890469	0.0756392518761187	1	1	0.856087573876627	0.907953738849157	0.647042823209975
down	NQO2; SHC1; S100A7; ARRB2; NOTCH1; GLIPR2; C5AR2; CCL5;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	8	209	3.82775119617225	0.015031261353488	0.0770881414132227	1	1	0.859380218391537	0.907953738849157	0.659437096730059
down	PNP; IL6; CCL5; TNFRSF13C;	GO:0042102~positive regulation of T cell proliferation	4	61	6.55737704918033	0.0151284357375299	0.0774501464032065	1	1	0.861123383134725	0.907953738849157	0.662533805448422
down	DYNLL1; CSNK2B; ATG101; ATG3; EI24;	GO:0016236~macroautophagy	5	94	5.31914893617021	0.0152302340655871	0.0778345119878162	1	1	0.861123383134725	0.907953738849157	0.665821793984029
down	PLEK; EXOC6; VTI1B;	GO:0006904~vesicle docking involved in exocytosis	3	33	9.09090909090909	0.0154801296743181	0.0786974131610622	1	1	0.86293627446764	0.907953738849157	0.673203331974421
down	PRNP; SRF; RELN;	GO:0007616~long-term memory	3	33	9.09090909090909	0.0154801296743181	0.0786974131610622	1	1	0.86293627446764	0.907953738849157	0.673203331974421
down	DDX3X; NGF; BID;	GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors	3	33	9.09090909090909	0.0154801296743181	0.0786974131610622	1	1	0.86293627446764	0.907953738849157	0.673203331974421
down	PRNP; THBS1; CXCL8; NOTCH1; MLF1; EIF4G2;	GO:0007050~cell cycle arrest	6	131	4.58015267175572	0.0156558272071141	0.0794519593280896	1	1	0.86293627446764	0.907953738849157	0.679657965911774
down	PRKAR2B; YWHAE; DYNLL1; IQCB1; MAPRE1;	GO:0097711~ciliary basal body-plasma membrane docking	5	95	5.26315789473684	0.0158447858980755	0.0802710631671198	1	1	0.864823161365164	0.907953738849157	0.686664847224882
down	SHC1; PPP2CA; ING3; MCTS1;	GO:0040008~regulation of growth	4	62	6.45161290322581	0.0159231043207424	0.0805277827887545	1	1	0.864823161365164	0.907953738849157	0.688860910573419
down	XRCC5; CCT8; NEK7;	GO:0032212~positive regulation of telomere maintenance via telomerase	3	34	8.82352941176471	0.0166667533916411	0.0839969768682537	1	1	0.86883781433862	0.907953738849157	0.718537527882365
down	COL5A1; ITGA3; KRT9;	GO:0043588~skin development	3	34	8.82352941176471	0.0166667533916411	0.0839969768682537	1	1	0.86883781433862	0.907953738849157	0.718537527882365
up	MCF2L; ABCA1; CXCL10; SSTR5; PLCB4; GPR158; ADM2; ARHGEF25; FZD10;	GO:0007186~G protein-coupled receptor signaling pathway	9	1152	0.78125	0.0166724647578421	0.0540231163257352	1	1	0.649842482529336	0.77535525035524	0.404280362742567
down	FH; SYK; MFAP2; ADIPOR2; ADIPOR1;	GO:0120162~positive regulation of cold-induced thermogenesis	5	97	5.15463917525773	0.0171229490674271	0.0845663724227053	1	1	0.87320932535416	0.907953738849157	0.723408323110205
down	FCHO1; ARPC3; TGFA; UBB; ARRB2; YWHAE;	GO:0061024~membrane organization	6	134	4.47761194029851	0.0172387573785577	0.0845663724227053	1	1	0.87320932535416	0.907953738849157	0.723408323110205
down	XRCC5; XRCC4; DDX1; APTX;	GO:0006302~double-strand break repair	4	64	6.25	0.0175898612034191	0.0858279157212058	1	1	0.875544109646551	0.907953738849157	0.734199975819835
down	ITGB3; CYBA; PGF; NCF4;	GO:0048010~vascular endothelial growth factor receptor signaling pathway	4	64	6.25	0.0175898612034191	0.0858279157212058	1	1	0.875544109646551	0.907953738849157	0.734199975819835
down	SERPINA1; TGFA; COL7A1; CNIH2;	GO:0048208~COPII vesicle coating	4	64	6.25	0.0175898612034191	0.0858279157212058	1	1	0.875544109646551	0.907953738849157	0.734199975819835
down	ARPC3; LYN; HCK; FCGR3A; FGR; SYK;	GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis	6	135	4.44444444444444	0.0177899416408629	0.0866299204346174	1	1	0.875544109646551	0.907953738849157	0.741060585637122
down	GNLY; RPL30; LCE3A;	GO:0031640~killing of cells of other organism	3	35	8.57142857142857	0.0179029221083555	0.0866299204346174	1	1	0.877243183309421	0.907953738849157	0.741060585637122
down	UBB; NMU; IRX3;	GO:0097009~energy homeostasis	3	35	8.57142857142857	0.0179029221083555	0.0866299204346174	1	1	0.877243183309421	0.907953738849157	0.741060585637122
down	TERT; SRF; GNL3;	GO:1902895~positive regulation of pri-miRNA transcription by RNA polymerase II	3	35	8.57142857142857	0.0179029221083555	0.0866299204346174	1	1	0.877243183309421	0.907953738849157	0.741060585637122
down	LCK; BID; IL20RA;	GO:2001244~positive regulation of intrinsic apoptotic signaling pathway	3	35	8.57142857142857	0.0179029221083555	0.0866299204346174	1	1	0.877243183309421	0.907953738849157	0.741060585637122
up	ABCA1; CXCL10; IL1B;	GO:0071222~cellular response to lipopolysaccharide	3	163	1.84049079754601	0.0184342184167292	0.0572862185328124	1	1	0.663631863002252	0.77535525035524	0.428699689757858
down	IDH3B; FH; SDHB;	GO:0006099~tricarboxylic acid cycle	3	36	8.33333333333333	0.0191887705564074	0.0919967004098245	1	1	0.883231814023935	0.907953738849157	0.786969771417966
down	HTR7; STAT1; OLR1;	GO:0008015~blood circulation	3	36	8.33333333333333	0.0191887705564074	0.0919967004098245	1	1	0.883231814023935	0.907953738849157	0.786969771417966
down	ATP6V1G1; ATP6V1E1; ATP6V0E2;	GO:0033572~transferrin transport	3	36	8.33333333333333	0.0191887705564074	0.0919967004098245	1	1	0.883231814023935	0.907953738849157	0.786969771417966
down	CTSV; LCP1; MMP9; ADAM8;	GO:0022617~extracellular matrix disassembly	4	66	6.06060606060606	0.019361329039906	0.0919967004098245	1	1	0.886050638962309	0.907953738849157	0.786969771417966
up	INPP4B; IL1B; CXCL10; REG1A; CASKIN1; DPYSL5; TRHDE; GABRD;	GO:0007165~signal transduction	8	989	0.808897876643074	0.0194967456310835	0.0572862185328124	1	1	0.66959078209338	0.77535525035524	0.428699689757858
down	HLA-B; HLA-H; HLA-G; STAT1;	GO:0060337~type I interferon signaling pathway	4	67	5.97014925373134	0.0202868432846022	0.0945529191808738	1	1	0.892133366460906	0.907953738849157	0.808836500256995
down	DDX3X; ISL1; CTNNBIP1;	GO:0031333~negative regulation of protein-containing complex assembly	3	37	8.10810810810811	0.0205243923714981	0.0953549521182996	1	1	0.892133366460906	0.907953738849157	0.815697351511702
down	UBB; RBX1; MRPS35;	GO:0042769~DNA damage response, detection of DNA damage	3	37	8.10810810810811	0.0205243923714981	0.0953549521182996	1	1	0.892133366460906	0.907953738849157	0.815697351511702
down	TGFB1I1; UBB; BAMBI; STRAP;	GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway	4	68	5.88235294117647	0.0212391288697031	0.0983618162121546	1	1	0.895421327270959	0.907953738849157	0.841419047377799
down	ENSA; SLC25A5; ALOX5; CCL5;	GO:0050796~regulation of insulin secretion	4	68	5.88235294117647	0.0212391288697031	0.0983618162121546	1	1	0.895421327270959	0.907953738849157	0.841419047377799
down	GDI2; RHOG; ARHGAP4; FGD2; PREX1; ARHGAP45;	GO:0051056~regulation of small GTPase mediated signal transduction	6	141	4.25531914893617	0.0213519824011585	0.0986140039428294	1	1	0.896783260848659	0.907953738849157	0.843576343453413
down	PTHLH; GNAL; UCN2; ADGRE2; ADGRL2;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	5	103	4.85436893203883	0.0213612895598783	0.0986140039428294	1	1	0.897174161514887	0.907953738849157	0.843576343453413
down	AIMP1; PPA1; FARSB;	GO:0006418~tRNA aminoacylation for protein translation	3	38	7.89473684210526	0.0219098416481061	0.100271069278444	1	1	0.898891952570459	0.907953738849157	0.857751420631007
down	GNAI3; DYSF; STX11;	GO:0006906~vesicle fusion	3	38	7.89473684210526	0.0219098416481061	0.100271069278444	1	1	0.898891952570459	0.907953738849157	0.857751420631007
down	CCL5; TYRO3; SMPD3;	GO:0043491~protein kinase B signaling	3	38	7.89473684210526	0.0219098416481061	0.100271069278444	1	1	0.898891952570459	0.907953738849157	0.857751420631007
down	TERT; ADIPOR2; ERFE;	GO:0046326~positive regulation of glucose import	3	38	7.89473684210526	0.0219098416481061	0.100271069278444	1	1	0.898891952570459	0.907953738849157	0.857751420631007
down	UNC13D; PREX1; HAS2;	GO:1900026~positive regulation of substrate adhesion-dependent cell spreading	3	38	7.89473684210526	0.0219098416481061	0.100271069278444	1	1	0.898891952570459	0.907953738849157	0.857751420631007
down	DYSF; IL11; CEBPD; ALOXE3;	GO:0045444~fat cell differentiation	4	70	5.71428571428571	0.0232246992813169	0.100271069278444	1	1	0.906445666457605	0.907953738849157	0.857751420631007
down	EGFLAM; LAMC2; LAMA3;	GO:0009888~tissue development	3	39	7.69230769230769	0.0233451344510603	0.100271069278444	1	1	0.907953738849157	0.907953738849157	0.857751420631007
down	NLRP12; RGS18; PAK1IP1;	GO:0009968~negative regulation of signal transduction	3	39	7.69230769230769	0.0233451344510603	0.100271069278444	1	1	0.907953738849157	0.907953738849157	0.857751420631007
down	PRNP; CCL5; RELN;	GO:0061098~positive regulation of protein tyrosine kinase activity	3	39	7.69230769230769	0.0233451344510603	0.100271069278444	1	1	0.907953738849157	0.907953738849157	0.857751420631007
down	DHX15; LYN; SRF; CCL5;	GO:0009636~response to toxic substance	4	71	5.63380281690141	0.024258298523042	0.100271069278444	1	1	0.907953738849157	0.907953738849157	0.857751420631007
down	ATP6V1G1; ATP6V1E1; ATP6V0E2; ATG101;	GO:0016241~regulation of macroautophagy	4	71	5.63380281690141	0.024258298523042	0.100271069278444	1	1	0.907953738849157	0.907953738849157	0.857751420631007
down	FDPS; CNBP; ACAT2;	GO:0006695~cholesterol biosynthetic process	3	40	7.5	0.0248302502870914	0.100271069278444	1	1	0.907953738849157	0.907953738849157	0.857751420631007
down	UBB; ARRB2; COMMD1; PRICKLE1;	GO:0031398~positive regulation of protein ubiquitination	4	72	5.55555555555556	0.0253192980700623	0.100271069278444	1	1	0.907953738849157	0.907953738849157	0.857751420631007
down	YWHAE; RYR2; CDH23;	GO:0051480~regulation of cytosolic calcium ion concentration	3	41	7.31707317073171	0.0263651335357601	0.100271069278444	1	1	0.907953738849157	0.907953738849157	0.857751420631007
down	CYP27B1; CCL5; RYR2; CDH23;	GO:0006816~calcium ion transport	4	74	5.40540540540541	0.0275240043865776	0.100271069278444	1	1	0.907953738849157	0.907953738849157	0.857751420631007
down	IL33; RBX1; PRICKLE1; PLK2;	GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process	4	74	5.40540540540541	0.0275240043865776	0.100271069278444	1	1	0.907953738849157	0.907953738849157	0.857751420631007
down	PFKFB2; ISL1; MCU;	GO:0032024~positive regulation of insulin secretion	3	42	7.14285714285714	0.0279496948419109	0.100271069278444	1	1	0.907953738849157	0.907953738849157	0.857751420631007
up	ABCA1; BDNF; MAP1B;	GO:0042493~response to drug	3	193	1.55440414507772	0.0283155989080617	0.0657425607415079	1	1	0.707112094414955	0.77535525035524	0.491982471798666
down	IMPDH2; HTR7; NDUFA9; ARNTL2;	GO:0007623~circadian rhythm	4	75	5.33333333333333	0.0286679368837277	0.100271069278444	1	1	0.907953738849157	0.907953738849157	0.857751420631007
down	CDH3; CDH23; CDH13;	GO:0007043~cell-cell junction assembly	3	43	6.97674418604651	0.0295838124678058	0.101985379548779	1	1	0.907953738849157	0.907953738849157	0.872416189645278
down	CDH3; CDH13; CDH23;	GO:0034332~adherens junction organization	3	43	6.97674418604651	0.0295838124678058	0.101985379548779	1	1	0.907953738849157	0.907953738849157	0.872416189645278
down	SPN; HLA-G; GLMN;	GO:0042130~negative regulation of T cell proliferation	3	43	6.97674418604651	0.0295838124678058	0.101985379548779	1	1	0.907953738849157	0.907953738849157	0.872416189645278
down	CDH13; RHOG; ARHGAP4; PDPN;	GO:0007266~Rho protein signal transduction	4	77	5.19480519480519	0.031039443592922	0.104893154508332	1	1	0.907953738849157	0.907953738849157	0.897290244747904
down	NES; TDG; CTNNBIP1; PIM2;	GO:0032091~negative regulation of protein binding	4	77	5.19480519480519	0.031039443592922	0.104893154508332	1	1	0.907953738849157	0.907953738849157	0.897290244747904
down	LYN; PPP2CA; SMPD3;	GO:0001932~regulation of protein phosphorylation	3	44	6.81818181818182	0.0312673336105932	0.105296812494402	1	1	0.907953738849157	0.907953738849157	0.900743266776021
down	THBD; STAT1; FOSB;	GO:0051591~response to cAMP	3	44	6.81818181818182	0.0312673336105932	0.105296812494402	1	1	0.907953738849157	0.907953738849157	0.900743266776021
down	IL33; TNFRSF1B; CD27;	GO:0097191~extrinsic apoptotic signaling pathway	3	44	6.81818181818182	0.0312673336105932	0.105296812494402	1	1	0.907953738849157	0.907953738849157	0.900743266776021
up	LMX1B; TPM1; FOXD3;	GO:0001701~in utero embryonic development	3	203	1.47783251231527	0.0321220096615942	0.0695258130373115	1	1	0.719021350741944	0.77535525035524	0.520294326325383
down	MAP2; NOTCH1; AFG3L2; ISL1;	GO:0007409~axonogenesis	4	78	5.12820512820513	0.032267178934535	0.10841325517451	1	1	0.907953738849157	0.907953738849157	0.927402333597725
down	IL33; NLRP12; IL1RL1; NLRP10;	GO:0050729~positive regulation of inflammatory response	4	78	5.12820512820513	0.032267178934535	0.10841325517451	1	1	0.907953738849157	0.907953738849157	0.927402333597725
down	SRF; CX3CR1; PTPRJ; DPYSL3; ARHGAP4;	GO:0030336~negative regulation of cell migration	5	116	4.31034482758621	0.0327391368240941	0.10974580617789	1	1	0.907953738849157	0.907953738849157	0.938801409367407
down	ATP6V1G1; COX7A2; ATP6V1E1; ATP6V0E2; SLC2A9;	GO:1902600~proton transmembrane transport	5	116	4.31034482758621	0.0327391368240941	0.10974580617789	1	1	0.907953738849157	0.907953738849157	0.938801409367407
down	KRT14; RRM1; LZIC;	GO:0010212~response to ionizing radiation	3	45	6.66666666666667	0.0330000756808915	0.109987666428417	1	1	0.907953738849157	0.907953738849157	0.940870360810502
down	EDN1; CYBA; BNIP1;	GO:0014823~response to activity	3	45	6.66666666666667	0.0330000756808915	0.109987666428417	1	1	0.907953738849157	0.907953738849157	0.940870360810502
down	CDH13; CDH23; CDH3;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	3	45	6.66666666666667	0.0330000756808915	0.109987666428417	1	1	0.907953738849157	0.907953738849157	0.940870360810502
down	EOMES; NOTCH1; PAX5;	GO:0035914~skeletal muscle cell differentiation	3	45	6.66666666666667	0.0330000756808915	0.109987666428417	1	1	0.907953738849157	0.907953738849157	0.940870360810502
down	GP1BA; THBS1; ITGA2B;	GO:0045652~regulation of megakaryocyte differentiation	3	45	6.66666666666667	0.0330000756808915	0.109987666428417	1	1	0.907953738849157	0.907953738849157	0.940870360810502
down	ZPR1; MAP2; BCCIP; TUBB1; CALM1;	GO:0000226~microtubule cytoskeleton organization	5	118	4.23728813559322	0.034767687238055	0.11328783128756	1	1	0.907953738849157	0.907953738849157	0.969101047055455
down	PPIG; FKBP10; PPIL1;	GO:0000413~protein peptidyl-prolyl isomerization	3	46	6.52173913043478	0.034781827546462	0.11328783128756	1	1	0.907953738849157	0.907953738849157	0.969101047055455
down	NOTCH1; ISL1; PLXND1;	GO:0003151~outflow tract morphogenesis	3	46	6.52173913043478	0.034781827546462	0.11328783128756	1	1	0.907953738849157	0.907953738849157	0.969101047055455
down	PLK2; BCCIP; SBDS;	GO:0007052~mitotic spindle organization	3	46	6.52173913043478	0.034781827546462	0.11328783128756	1	1	0.907953738849157	0.907953738849157	0.969101047055455
down	DYRK3; LYN; ALAS2;	GO:0030218~erythrocyte differentiation	3	46	6.52173913043478	0.034781827546462	0.11328783128756	1	1	0.907953738849157	0.907953738849157	0.969101047055455
down	CA1; SNRPA1; LCP1;	GO:0035722~interleukin-12-mediated signaling pathway	3	46	6.52173913043478	0.034781827546462	0.11328783128756	1	1	0.907953738849157	0.907953738849157	0.969101047055455
down	TGFB1I1; IL6; GPS2;	GO:0045599~negative regulation of fat cell differentiation	3	46	6.52173913043478	0.034781827546462	0.11328783128756	1	1	0.907953738849157	0.907953738849157	0.969101047055455
down	CCL5; PGF; PTPRJ;	GO:0050918~positive chemotaxis	3	46	6.52173913043478	0.034781827546462	0.11328783128756	1	1	0.907953738849157	0.907953738849157	0.969101047055455
down	PRKAR2B; YWHAE; DYNLL1; MAPRE1;	GO:0010389~regulation of G2/M transition of mitotic cell cycle	4	80	5	0.0348069375222677	0.11328783128756	1	1	0.907953738849157	0.907953738849157	0.969101047055455
down	ENC1; TIMM8A; DSCAM; FGF5; NINJ1; NINJ2; UTP11; BZW2; TYRO3;	GO:0007399~nervous system development	9	294	3.06122448979592	0.0352862464277321	0.114719682861589	1	1	0.907953738849157	0.907953738849157	0.981349572284062
down	CD27; SH3RF3; CARD9; TRAF5;	GO:0046330~positive regulation of JNK cascade	4	81	4.93827160493827	0.0361190592725422	0.116624544268791	1	1	0.907953738849157	0.907953738849157	0.997644377853511
down	IGF2; ITGB3; LYN; MMP9; PLAUR; PGF;	GO:0001934~positive regulation of protein phosphorylation	6	161	3.72670807453416	0.0366073643777024	0.116624544268791	1	1	0.907953738849157	0.907953738849157	0.997644377853511
down	ADIPOR2; ADIPOR1; UCN2;	GO:0009755~hormone-mediated signaling pathway	3	47	6.38297872340426	0.0366123507417767	0.116624544268791	1	1	0.907953738849157	0.907953738849157	0.997644377853511
down	STAT1; EIF2B2; EIF2B3;	GO:0043434~response to peptide hormone	3	47	6.38297872340426	0.0366123507417767	0.116624544268791	1	1	0.907953738849157	0.907953738849157	0.997644377853511
down	IMPA2; CALM1; PLCB2;	GO:0043647~inositol phosphate metabolic process	3	47	6.38297872340426	0.0366123507417767	0.116624544268791	1	1	0.907953738849157	0.907953738849157	0.997644377853511
down	DDX3X; CYBA; EIF4G2; KRT17;	GO:0030307~positive regulation of cell growth	4	82	4.8780487804878	0.0374593913567839	0.116624544268791	1	1	0.907953738849157	0.907953738849157	0.997644377853511
down	DSCAM; DOK2; SHC1; RELN; SEMA3B; ENAH; DOK1;	GO:0007411~axon guidance	7	206	3.39805825242718	0.037864826110956	0.116624544268791	1	1	0.907953738849157	0.907953738849157	0.997644377853511
down	MASTL; WDR12; TXLNG; USP16; E2F2;	GO:0051726~regulation of cell cycle	5	121	4.13223140495868	0.0379533139453283	0.116624544268791	1	1	0.907953738849157	0.907953738849157	0.997644377853511
down	UBB; MAP2K4; GPS2;	GO:0007254~JNK cascade	3	48	6.25	0.0384913806426868	0.116624544268791	1	1	0.907953738849157	0.907953738849157	0.997644377853511
up	IL1B; PAX3; LGALS7; RNF152; CADM1;	GO:0006915~apoptotic process	5	552	0.905797101449275	0.039796999568581	0.0762330241256119	1	1	0.726897902003185	0.77535525035524	0.570487538346314
down	DSCAM; CEACAM5; CDH13; FAT1; CDH23; CDH3;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	6	165	3.63636363636364	0.0403212749028921	0.116624544268791	1	1	0.907953738849157	0.907953738849157	0.997644377853511
down	MEFV; PLK2; PIM2;	GO:0010508~positive regulation of autophagy	3	49	6.12244897959184	0.0404186276077378	0.116624544268791	1	1	0.907953738849157	0.907953738849157	0.997644377853511
down	CD33; ARRB2; C5AR2;	GO:0032720~negative regulation of tumor necrosis factor production	3	49	6.12244897959184	0.0404186276077378	0.116624544268791	1	1	0.907953738849157	0.907953738849157	0.997644377853511
up	IL1B; HSPG2; PLA2G4C; CXCL10;	GO:0006954~inflammatory response	4	381	1.0498687664042	0.0408033889903048	0.0780110770351038	1	1	0.729148359904124	0.77535525035524	0.583793543703181
down	ADGRL2; PPBP; EDN1; GNAI3; CALM1; CXCL8; PTHLH; CCL5; GNAZ; CXCR1; CXCR2; ARRB2; HTR7; RGS2; GRK6; NMU; CX3CR1; PLCB2; BTK; FGD2; GPRC5A; PREX1; OXER1; RGS18; ADGRE2;	GO:0007186~G protein-coupled receptor signaling pathway	25	1152	2.17013888888889	0.0421350875200729	0.116624544268791	1	1	0.907953738849157	0.907953738849157	0.997644377853511
down	STAT1; HBB; APTX;	GO:0042542~response to hydrogen peroxide	3	50	6	0.0423937780874915	0.116624544268791	1	1	0.907953738849157	0.907953738849157	0.997644377853511
down	LCK; RYR2; PLCB2;	GO:0051209~release of sequestered calcium ion into cytosol	3	50	6	0.0423937780874915	0.116624544268791	1	1	0.907953738849157	0.907953738849157	0.997644377853511
down	UBB; NUP54; NUP210;	GO:0075733~intracellular transport of virus	3	50	6	0.0423937780874915	0.116624544268791	1	1	0.907953738849157	0.907953738849157	0.997644377853511
up	IL1B; CXCL10; TRHDE;	GO:0007267~cell-cell signaling	3	230	1.30434782608696	0.0436585144878688	0.0809873558715485	1	1	0.73168012504268	0.77535525035524	0.60606643666933
down	TRIAP1; EIF2S1; RPL26;	GO:0034644~cellular response to UV	3	51	5.88235294117647	0.0444164957024931	0.118702066037947	1	1	0.907953738849157	0.907953738849157	1
down	LYN; FGR; CCL5; RELN;	GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling	4	87	4.59770114942529	0.0445847035442837	0.118933371267856	1	1	0.907953738849157	0.907953738849157	1
down	ITGB3; ITGB6; TYRO3; SELPLG;	GO:0046718~viral entry into host cell	4	87	4.59770114942529	0.0445847035442837	0.118933371267856	1	1	0.907953738849157	0.907953738849157	1
down	TERT; SSBP1; YME1L1; TFB2M;	GO:0007005~mitochondrion organization	4	88	4.54545454545455	0.0460944605691525	0.122735981387515	1	1	0.907953738849157	0.907953738849157	1
down	HSPA4L; THBS1; HSPA6;	GO:0006986~response to unfolded protein	3	52	5.76923076923077	0.0464864222894508	0.123328732358078	1	1	0.907953738849157	0.907953738849157	1
down	GNLY; S100A7; SLC11A1;	GO:0019730~antimicrobial humoral response	3	52	5.76923076923077	0.0464864222894508	0.123328732358078	1	1	0.907953738849157	0.907953738849157	1
down	ALDH3B1; ACER1; ELOVL7;	GO:0030148~sphingolipid biosynthetic process	3	52	5.76923076923077	0.0464864222894508	0.123328732358078	1	1	0.907953738849157	0.907953738849157	1
down	PRNP; NQO2; MAP2K4;	GO:0043525~positive regulation of neuron apoptotic process	3	52	5.76923076923077	0.0464864222894508	0.123328732358078	1	1	0.907953738849157	0.907953738849157	1
down	CX3CR1; BVES; PANX2;	GO:0002931~response to ischemia	3	53	5.66037735849057	0.048603178917779	0.127435697738515	1	1	0.907953738849157	0.907953738849157	1
down	EDN1; NMU; ALOXE3;	GO:0019233~sensory perception of pain	3	53	5.66037735849057	0.048603178917779	0.127435697738515	1	1	0.907953738849157	0.907953738849157	1
down	LCK; LYN; TNFRSF13C;	GO:0031295~T cell costimulation	3	53	5.66037735849057	0.048603178917779	0.127435697738515	1	1	0.907953738849157	0.907953738849157	1
down	TSPAN2; EIF2B2; AFG3L2;	GO:0042552~myelination	3	53	5.66037735849057	0.048603178917779	0.127435697738515	1	1	0.907953738849157	0.907953738849157	1
down	DDX3X; SYK; CARD9;	GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	3	53	5.66037735849057	0.048603178917779	0.127435697738515	1	1	0.907953738849157	0.907953738849157	1
down	PRNP; ITGA3; RHOG;	GO:1903078~positive regulation of protein localization to plasma membrane	3	53	5.66037735849057	0.048603178917779	0.127435697738515	1	1	0.907953738849157	0.907953738849157	1
down	CCL5; STX11; EXOC6; TNFAIP2;	GO:0006887~exocytosis	4	90	4.44444444444444	0.0491984597227593	0.128880497457192	1	1	0.907953738849157	0.907953738849157	1
